{"title":"Peptides Australia","description":"\u003cp\u003eBrowse our complete range of research peptides supplied in Australia. Every product on this page is third-party HPLC tested for purity, batch-traceable, and dispatched next business day from our Sydney facility. All products are supplied strictly for laboratory and research use only — not for human or animal consumption.\u003c\/p\u003e\n\u003cp\u003eFor more on what research peptides are and how they're handled, see our \u003ca href=\"\/pages\/about\"\u003eAbout page\u003c\/a\u003e or browse the \u003ca href=\"\/pages\/labreports\"\u003eCOA library\u003c\/a\u003e.\u003c\/p\u003e","products":[{"product_id":"reta-10mg-15mg-20mg-30mg","title":"Retatrutide 5mg \/ 10mg \/ 15mg \/ 20mg \/ 30mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity Retatrutide in Australia (5mg \/ 10mg \/ 15mg \/ 20mg \/ 30mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout Retatrutide\u003c\/h2\u003e\n\u003cp\u003eRetatrutide (research code LY-3437943) is a synthetic 39-amino-acid peptide developed by Eli Lilly as a novel triple agonist of the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIP-R), and glucagon receptor (GCG-R). Optic Labs supplies retatrutide as a high-purity lyophilised powder in 5mg, 10mg, 15mg, 20mg and 30mg vials, packaged for in vitro and preclinical laboratory research.\u003c\/p\u003e\n\n\u003cp\u003eEach batch is independently HPLC-tested for purity and identity, with certificates of analysis available on request.\u003c\/p\u003e\n\n\u003cp\u003eRetatrutide is one of the most actively studied compounds in the metabolic and obesity research literature, following published Phase 2 clinical trial data showing substantial reductions in body weight in human study populations. Optic Labs supplies retatrutide for laboratory research only — not for human consumption, clinical use, or any therapeutic application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Retatrutide (LY-3437943)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 2381089-83-2\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e221\u003c\/sub\u003eH\u003csub\u003e343\u003c\/sub\u003eN\u003csub\u003e51\u003c\/sub\u003eO\u003csub\u003e61\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~4731.5 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMechanism (research context):\u003c\/strong\u003e Triple agonist — GLP-1R + GIP-R + GCG-R\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised (freeze-dried) white powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 5mg, 10mg, 15mg, 20mg, 30mg vials\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store unreconstituted vials at 2–8°C; protect from light. Reconstituted solution stored at 2–8°C and used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eRetatrutide was developed as a successor compound to dual incretin agonists (such as tirzepatide), adding glucagon receptor agonism to the GLP-1\/GIP profile. Published preclinical and clinical research has examined retatrutide in the context of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eGLP-1, GIP and glucagon receptor binding, signalling and downstream pathways\u003c\/li\u003e\n\u003cli\u003eBody composition and adiposity in animal models\u003c\/li\u003e\n\u003cli\u003eEnergy expenditure and thermogenesis (glucagon-receptor contribution)\u003c\/li\u003e\n\u003cli\u003eHepatic lipid metabolism and NAFLD\/MASH research models\u003c\/li\u003e\n\u003cli\u003eGlycaemic control and insulin sensitivity in T2D models\u003c\/li\u003e\n\u003cli\u003ePhase 1 and Phase 2 clinical pharmacokinetic and weight-change studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary with study citations, see our \u003ca href=\"\/blogs\/news\/retatrutide-triple-agonist-complete-guide\"\u003ecomplete retatrutide research guide\u003c\/a\u003e, our \u003ca href=\"\/blogs\/news\/retatrutide-australia-triple-agonist-guide\"\u003eAustralian retatrutide guide\u003c\/a\u003e, our \u003ca href=\"\/blogs\/news\/retatrutide-side-effects-clinical-trial-analysis\"\u003eclinical trial side-effects analysis\u003c\/a\u003e, and our \u003ca href=\"\/blogs\/news\/retatrutide-dosing-titration-protocol-guide\"\u003edosing and titration protocol research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use in any laboratory protocol. A 10mg vial reconstituted in 2mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a working concentration of 5mg\/mL; 1mL yields 10mg\/mL.\u003c\/p\u003e\n\n\u003cp\u003eLarger vial sizes scale proportionally. Exact volumes should be calculated for each protocol — our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e walks through the maths. Reconstituted vials should be stored refrigerated at 2–8°C and protected from light.\u003c\/p\u003e\n\n\u003ch2\u003eComparisons and related research compounds\u003c\/h2\u003e\n\u003cp\u003eRetatrutide sits within the broader class of incretin and metabolic peptides. Researchers may also be interested in:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/aod-9604-5mg\"\u003eAOD-9604\u003c\/a\u003e — fragment growth-hormone analogue, fat-loss research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tesamorelin-10mg\"\u003eTesamorelin\u003c\/a\u003e — GHRH analogue, lipolysis research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/cjc-1295-no-dac-ipamorelin-10mg\"\u003eCJC-1295 + Ipamorelin\u003c\/a\u003e — growth-hormone-releasing research peptide combination\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/5-amino-1mq-10mg\"\u003e5-Amino-1MQ\u003c\/a\u003e — NNMT inhibitor, metabolic research\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a direct comparison between AOD-9604 and retatrutide research profiles, see our \u003ca href=\"\/blogs\/news\/aod-9604-vs-retatrutide\"\u003eAOD-9604 vs retatrutide article\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs retatrutide legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eRetatrutide is not currently approved by the Therapeutic Goods Administration (TGA) for therapeutic use in Australia — the compound remains in clinical-trial development. Optic Labs supplies retatrutide strictly as a research chemical for in vitro and preclinical laboratory research — not for human consumption, clinical use or any therapeutic application. For a detailed overview, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is retatrutide?\u003c\/h3\u003e\n\u003cp\u003eRetatrutide (LY-3437943) is a synthetic 39-amino-acid peptide developed as a triple agonist of the GLP-1, GIP and glucagon receptors. In published research it has been investigated for its effects on body composition, glycaemic control, hepatic lipid metabolism and energy expenditure. See our \u003ca href=\"\/blogs\/news\/retatrutide-triple-agonist-complete-guide\"\u003ecomplete research guide\u003c\/a\u003e for background.\u003c\/p\u003e\n\n\u003ch3\u003eHow does retatrutide differ from semaglutide and tirzepatide?\u003c\/h3\u003e\n\u003cp\u003eSemaglutide is a single GLP-1 receptor agonist. Tirzepatide is a dual GLP-1 + GIP agonist. Retatrutide adds a third receptor target — the glucagon receptor — making it a triple agonist. The published research literature suggests glucagon-receptor agonism contributes to energy expenditure effects beyond what is seen with GLP-1 alone or GLP-1 + GIP. Our \u003ca href=\"\/blogs\/news\/retatrutide-triple-agonist-complete-guide\"\u003eresearch guide\u003c\/a\u003e covers the comparisons.\u003c\/p\u003e\n\n\u003ch3\u003eHow is retatrutide supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies retatrutide as a lyophilised powder in glass research vials, available in 5mg, 10mg, 15mg, 20mg and 30mg sizes. Each vial is sealed and shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a retatrutide vial?\u003c\/h3\u003e\n\u003cp\u003eReconstitution volume depends on the vial size and the working concentration required by the research protocol. As a starting reference: 10mg in 2mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields 5mg\/mL; 20mg in 2mL yields 10mg\/mL. Our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution guide\u003c\/a\u003e covers the calculations across all vial sizes.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted retatrutide be stored?\u003c\/h3\u003e\n\u003cp\u003eUnreconstituted vials should be stored at 2–8°C and protected from light. Once reconstituted, the solution should be refrigerated at 2–8°C and used within approximately 30 days. For full storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease.\u003c\/p\u003e\n\n\u003cp\u003eOptic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"5mg","offer_id":53364520157368,"sku":null,"price":94.99,"currency_code":"AUD","in_stock":true},{"title":"10mg","offer_id":53360883630264,"sku":null,"price":142.99,"currency_code":"AUD","in_stock":false},{"title":"15mg","offer_id":53360883663032,"sku":null,"price":180.99,"currency_code":"AUD","in_stock":false},{"title":"20mg","offer_id":53360883695800,"sku":null,"price":213.99,"currency_code":"AUD","in_stock":true},{"title":"30mg","offer_id":53360883728568,"sku":null,"price":265.99,"currency_code":"AUD","in_stock":true},{"title":"60mg","offer_id":53474336899256,"sku":null,"price":359.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/reta5.png?v=1776426193"},{"product_id":"ghk-cu-50mg-100mg","title":"GHK-CU 50mg \/ 100mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity GHK-Cu (copper peptide) in Australia (50mg \/ 100mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout GHK-Cu\u003c\/h2\u003e\n\u003cp\u003eGHK-Cu is a naturally occurring copper-binding tripeptide complex consisting of the amino-acid sequence Glycyl-L-Histidyl-L-Lysine bound to a divalent copper ion (Cu\u003csup\u003e2+\u003c\/sup\u003e). First isolated from human plasma in the 1970s, GHK-Cu is one of the most extensively studied copper peptides in the dermatology, regenerative biology and gene-expression literature. Optic Labs supplies GHK-Cu as a high-purity lyophilised powder in 50mg and 100mg vials, packaged for in vitro and preclinical laboratory research. Each batch is independently HPLC-tested for purity and identity, with certificates of analysis available on request.\u003c\/p\u003e\n\n\u003cp\u003ePublished research has investigated GHK-Cu in models of collagen and elastin synthesis, fibroblast activity, antioxidant gene expression, copper transport, and skin-regeneration signalling. Optic Labs supplies the compound for laboratory research only — not for human consumption, clinical use, or any therapeutic application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e GHK-Cu (Copper tripeptide-1)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 89030-95-5\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e14\u003c\/sub\u003eH\u003csub\u003e23\u003c\/sub\u003eCuN\u003csub\u003e6\u003c\/sub\u003eO\u003csub\u003e4\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~402.91 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e Glycyl-L-Histidyl-L-Lysine + Cu\u003csup\u003e2+\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder (characteristic blue colour from copper coordination)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 50mg vial \/ 100mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store unreconstituted vials at 2–8°C; protect from light. Reconstituted solution stored at 2–8°C and used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eGHK was first identified in 1973 by Pickart as a factor in human plasma that altered the gene expression of cultured liver cells. The peptide naturally chelates Cu\u003csup\u003e2+\u003c\/sup\u003e with high affinity, forming the GHK-Cu complex. Published preclinical studies have examined GHK-Cu in the context of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eType I and III collagen synthesis in dermal fibroblast cultures\u003c\/li\u003e\n\u003cli\u003eElastin, glycosaminoglycan and decorin production\u003c\/li\u003e\n\u003cli\u003eAntioxidant defence gene expression (SOD, catalase pathways)\u003c\/li\u003e\n\u003cli\u003eCopper transport and lysyl oxidase activity\u003c\/li\u003e\n\u003cli\u003eHair-follicle stem cell and skin barrier research\u003c\/li\u003e\n\u003cli\u003eGenome-wide gene expression modulation studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary with study citations, see our \u003ca href=\"\/blogs\/news\/ghk-cu-australia-copper-peptide-guide\"\u003eGHK-Cu copper peptide guide\u003c\/a\u003e, our \u003ca href=\"\/blogs\/news\/ghk-cu-collagen-skin-regeneration-research\"\u003ecollagen and skin regeneration research article\u003c\/a\u003e, and our \u003ca href=\"\/blogs\/news\/ghk-cu-anti-ageing-peptide\"\u003eanti-ageing peptide research article\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eGHK-Cu is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use in any laboratory protocol. Typical reconstitution volumes for a 50mg vial range from 2mL to 5mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e (yielding 25mg\/mL or 10mg\/mL respectively); a 100mg vial reconstituted in 5mL yields 20mg\/mL. Exact volumes should be calculated for each protocol — our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e walks through the maths. Reconstituted solution typically displays a characteristic blue colour from the copper coordination. Store refrigerated at 2–8°C and protect from light.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eGHK-Cu is frequently studied alongside other regenerative and skin-related peptides in published research. Researchers may also be interested in:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/bpc-157\"\u003eBPC-157\u003c\/a\u003e — tissue repair and angiogenesis research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tb-500\"\u003eTB-500\u003c\/a\u003e — cell migration and wound-healing research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glow70-bpc-157-10mg-ghk-cu-50mg-tb-500-10mg\"\u003eGLOW Stack\u003c\/a\u003e — pre-mixed BPC-157 + GHK-Cu + TB-500 combination\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/klow80-bpc-157-10mg-ghk-cu-50mg-tb-500-10mg-kpv-10mg\"\u003eKLOW Stack\u003c\/a\u003e — adds KPV for inflammatory pathway research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/epithalong-10mg\"\u003eEpithalon\u003c\/a\u003e — telomere and longevity research\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs GHK-Cu legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eGHK-Cu is not currently approved by the Therapeutic Goods Administration (TGA) for therapeutic use in Australia. Optic Labs supplies GHK-Cu strictly as a research chemical for in vitro and preclinical laboratory research — not for human consumption, clinical use or any therapeutic application. For a detailed overview, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is GHK-Cu?\u003c\/h3\u003e\n\u003cp\u003eGHK-Cu is a naturally occurring tripeptide-copper complex (Glycyl-L-Histidyl-L-Lysine bound to Cu\u003csup\u003e2+\u003c\/sup\u003e) originally isolated from human plasma. In published research it has been investigated for its effects on collagen synthesis, fibroblast activity, antioxidant gene expression and skin-regeneration signalling. See our \u003ca href=\"\/blogs\/news\/ghk-cu-australia-copper-peptide-guide\"\u003eGHK-Cu copper peptide guide\u003c\/a\u003e for background.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is the difference between GHK and GHK-Cu?\u003c\/h3\u003e\n\u003cp\u003eGHK is the bare tripeptide. GHK-Cu refers to the same tripeptide bound to a divalent copper ion. Most published research and the commercially available research-grade material is supplied as the copper-bound complex, which is the biologically active form in published cell-culture and animal studies.\u003c\/p\u003e\n\n\u003ch3\u003eWhy is reconstituted GHK-Cu blue?\u003c\/h3\u003e\n\u003cp\u003eThe blue colour comes from the copper(II) ion coordinated to the peptide. This is normal and expected for a properly formulated GHK-Cu complex. Loss of colour over time can indicate degradation or copper dissociation, so storage protocols matter.\u003c\/p\u003e\n\n\u003ch3\u003eHow is GHK-Cu supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies GHK-Cu as a lyophilised powder in glass research vials, available in 50mg and 100mg sizes. Each vial is sealed and shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted GHK-Cu be stored?\u003c\/h3\u003e\n\u003cp\u003eUnreconstituted vials should be stored at 2–8°C and protected from light. Once reconstituted, the solution should be refrigerated at 2–8°C, kept away from light, and used within approximately 30 days. For full storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"50mg","offer_id":53360883990712,"sku":null,"price":61.99,"currency_code":"AUD","in_stock":true},{"title":"100mg","offer_id":53360884023480,"sku":null,"price":104.99,"currency_code":"AUD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/ghk50.png?v=1776426194"},{"product_id":"thymosin-alpha-1-10mg","title":"Thymosin Alpha-1 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity Thymosin Alpha-1 in Australia (10mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout Thymosin Alpha-1\u003c\/h2\u003e\n\u003cp\u003eThymosin Alpha-1 (Tα1, also written as thymosin α-1 or TA-1) is a 28-amino-acid acetylated peptide derived from the N-terminus of prothymosin α. First isolated from calf thymus by Allan Goldstein and colleagues in 1977, Tα1 has been characterised in published research as one of the most-studied immunomodulatory peptides, with a body of literature spanning toll-like-receptor signalling, T-cell maturation and cytokine modulation in cell-culture and animal models.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies Thymosin Alpha-1 in Australia as a lyophilised powder, 10mg per vial, third-party HPLC verified at \u0026gt;99% purity. The compound is provided strictly for laboratory research, including in-vitro innate-immunity assays, cell-culture cytokine-profiling work and animal studies of viral, oncological and immune-deficiency models. Thymosin Alpha-1 is supplied for research use only and is not intended for human consumption, clinical, cosmetic, diagnostic or veterinary application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Thymosin Alpha-1 (Tα1, TA-1)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 62304-98-7\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e129\u003c\/sub\u003eH\u003csub\u003e215\u003c\/sub\u003eN\u003csub\u003e33\u003c\/sub\u003eO\u003csub\u003e55\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~3108.3 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN (28-mer, N-terminal acetylated)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eThymosin Alpha-1 has been a tool of choice for immunomodulatory peptide research for nearly five decades. The peptide signals through toll-like receptor 9 (TLR9) and TLR2 in published research, modulating innate-immunity pathways and influencing T-cell development. Tα1 has progressed through clinical research programmes for chronic hepatitis B and C, sepsis and certain immunocompromised states in some jurisdictions, and remains a widely cited reference compound in laboratory immunology research.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTLR9 and TLR2 signalling research in dendritic cells and macrophage cell-culture models.\u003c\/li\u003e\n\u003cli\u003eT-cell maturation and Th1-skewing studies in thymic stromal and peripheral T-cell research models.\u003c\/li\u003e\n\u003cli\u003eNatural killer (NK) cell activity and cytokine-profiling research in cultured peripheral blood mononuclear cells.\u003c\/li\u003e\n\u003cli\u003eAntiviral pathway research in cell-culture models of hepatitis B, hepatitis C and respiratory viral infection.\u003c\/li\u003e\n\u003cli\u003eSepsis and critical-illness immunology research in rodent models examining immunoparalysis and recovery dynamics.\u003c\/li\u003e\n\u003cli\u003eOncology-adjacent research on Tα1 as an immunomodulatory adjunct in animal-tumour models.\u003c\/li\u003e\n\u003cli\u003eVaccine-adjuvant research in rodent immunisation models examining antibody titres and cellular response.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader peptide-research context, see our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eThymosin Alpha-1 is supplied lyophilised and should be reconstituted with sterile \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e for laboratory use. A common working approach is to add 2mL of bacteriostatic water to a 10mg vial, yielding a 5mg\/mL stock; 1mL gives 10mg\/mL for more concentrated workflows. Add the diluent slowly down the side of the vial — do not inject directly onto the lyophilised cake — and allow the powder to dissolve without vigorous shaking. Reconstituted Tα1 should be stored at 2–8°C, protected from light, and used within 30 days. For a step-by-step volume calculator and worked examples for any vial size, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution calculator guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eThymosin Alpha-1 is frequently studied alongside other peptides relevant to immunomodulatory, anti-inflammatory and tissue-repair pathways:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/kpv-10mg\"\u003eKPV\u003c\/a\u003e — α-MSH-derived tripeptide examined in NF-κB modulation and gut-barrier research, complementary to Tα1 in inflammation-research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/bpc-157\"\u003eBPC-157\u003c\/a\u003e — pentadecapeptide widely studied in tissue-repair models, often paired with immunomodulatory tools.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tb-500\"\u003eTB-500\u003c\/a\u003e — thymosin β-4 fragment; researchers commonly examine the thymosin α and β families in parallel for context.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glutathione-1500mg\"\u003eGlutathione\u003c\/a\u003e — endogenous antioxidant tripeptide used as a reference compound in oxidative-stress and immune-cell-redox assays.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/selank-10mg\"\u003eSelank\u003c\/a\u003e — tuftsin-derived heptapeptide examined in immunomodulatory and anxiolytic research.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader stack-design context, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs Thymosin Alpha-1 legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eThymosin Alpha-1 is not an approved therapeutic good in Australia and is not registered with the Therapeutic Goods Administration (TGA). Optic Labs supplies Tα1 strictly for laboratory research, development and analytical use — not for human consumption, clinical or cosmetic application. For a detailed overview of how research peptides sit within the Australian regulatory framework, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is Thymosin Alpha-1?\u003c\/h3\u003e\n\u003cp\u003eThymosin Alpha-1 is a 28-amino-acid acetylated peptide derived from the N-terminus of prothymosin α, originally isolated from calf thymus in 1977. It is one of the most extensively studied immunomodulatory peptides in published research, with a literature spanning TLR9\/TLR2 signalling, T-cell maturation and cytokine modulation. For a plain-language overview of peptide structure and research use, see our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eHow does Thymosin Alpha-1 differ from TB-500 (thymosin β-4)?\u003c\/h3\u003e\n\u003cp\u003eDespite their similar names, the two peptides come from distinct families and are studied for different purposes. Thymosin Alpha-1 is a 28-amino-acid α-thymosin investigated in immunomodulatory research — TLR signalling, T-cell maturation and cytokine modulation. TB-500 is a 17-amino-acid fragment of thymosin β-4, studied for actin-cytoskeleton remodelling, cell migration and tissue-repair pathways. Researchers examining both immune and repair endpoints sometimes run them in parallel rather than as substitutes — see our \u003ca href=\"\/blogs\/news\/tb-500-australia-thymosin-injury-research-guide\"\u003eTB-500 research guide\u003c\/a\u003e for context.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a Thymosin Alpha-1 10mg vial?\u003c\/h3\u003e\n\u003cp\u003eFor a 10mg vial, 2mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e gives a 5mg\/mL stock; 1mL gives 10mg\/mL. Choose the dilution that matches the volumes typical of your research protocol. See our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e for worked examples.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted Thymosin Alpha-1 be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted Tα1 should be stored at 2–8°C, protected from light, and used within 30 days. Lyophilised vials are stable at 2–8°C until reconstitution. For full handling guidance, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884056248,"sku":null,"price":94.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/thymosin_62b81b7b-231a-41bf-9a52-04630e627e3e.png?v=1776429260"},{"product_id":"tesamorelin-10mg","title":"Tesamorelin 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity tesamorelin (10mg) in Australia. Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout tesamorelin\u003c\/h2\u003e\n\u003cp\u003eTesamorelin is a synthetic 44-amino-acid analogue of human growth hormone-releasing hormone (GHRH 1–44), modified at the N-terminus with a trans-3-hexenoyl group that markedly increases its resistance to enzymatic degradation by dipeptidyl peptidase IV (DPP-IV). The modification gives tesamorelin a substantially longer functional half-life than native GHRH while preserving its ability to bind and activate the GHRH receptor on pituitary somatotrophs.\u003c\/p\u003e\n\n\u003cp\u003eIn published research, tesamorelin is one of the most extensively characterised GHRH analogues, with study interest concentrated on the GH\/IGF-1 axis, visceral adipose tissue dynamics and metabolic markers in animal and human research populations.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies tesamorelin as a lyophilised powder in 10mg research vials, third-party HPLC tested to \u0026gt;99% purity. The product is distributed Australian-domestic from Sydney, NSW, for in vitro and laboratory research applications. Tesamorelin is supplied strictly for laboratory research, development or analytical use and is not intended for human consumption.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Tesamorelin (trans-3-hexenoyl-GHRH 1–44)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 218949-48-5\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e221\u003c\/sub\u003eH\u003csub\u003e366\u003c\/sub\u003eN\u003csub\u003e72\u003c\/sub\u003eO\u003csub\u003e67\u003c\/sub\u003eS\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~5196 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH\u003csub\u003e2\u003c\/sub\u003e (44 amino acids)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable size:\u003c\/strong\u003e 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eTesamorelin was originally developed by Theratechnologies in the early 2000s as a stabilised analogue of human GHRH, with the trans-3-hexenoyl N-terminal modification specifically engineered to resist DPP-IV cleavage.\u003c\/p\u003e\n\n\u003cp\u003eThe compound has been extensively studied in published clinical and preclinical research, most notably in the context of HIV-associated visceral adipose tissue accumulation, where it became the first GHRH analogue to receive a regulatory indication in that population.\u003c\/p\u003e\n\n\u003cp\u003eIn Australian and broader research contexts, tesamorelin is examined as a research-use compound for studying GHRH-axis biology.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHRH receptor pharmacology:\u003c\/strong\u003e in pituitary cell-culture studies, tesamorelin binds the GHRH receptor with affinity comparable to native GHRH 1–44 and stimulates pulsatile growth hormone release through the cAMP\/PKA pathway.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGH and IGF-1 axis research:\u003c\/strong\u003e in published research populations, tesamorelin administration has been associated with sustained increases in endogenous GH pulse amplitude and downstream IGF-1, without the supraphysiological GH exposures seen with exogenous recombinant GH.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVisceral adipose tissue research:\u003c\/strong\u003e in published lipodystrophy studies, tesamorelin has been investigated for its effects on visceral adipose tissue volume measured by CT or MRI, with research interest in the lipolytic effects of restored physiological GH pulsatility.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic markers:\u003c\/strong\u003e research has examined effects on triglycerides, non-HDL cholesterol, adiponectin and hepatic fat fraction in study populations with metabolic dysregulation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHepatic steatosis models:\u003c\/strong\u003e in published research on non-alcoholic fatty liver disease (NAFLD) cohorts, tesamorelin has been studied for effects on liver fat content and markers of hepatic inflammation and fibrosis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCognitive and neurological research:\u003c\/strong\u003e exploratory research has examined tesamorelin in the context of GH-axis modulation and cognitive performance in older research populations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePharmacokinetic stability:\u003c\/strong\u003e the trans-3-hexenoyl modification gives tesamorelin a functional duration of action sufficient to support once-daily dosing protocols in published research, in contrast to the very short half-life of native GHRH.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a plain-language overview of peptides, see our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e, and for laboratory injection protocols our \u003ca href=\"\/blogs\/news\/how-to-inject-peptides-subcutaneous-protocol\"\u003esubcutaneous injection protocol article\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eTesamorelin is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use in any laboratory protocol. A common laboratory approach for the 10mg vial is reconstitution in 2ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e to yield a 5mg\/ml working stock, or in 1ml for a 10mg\/ml stock.\u003c\/p\u003e\n\n\u003cp\u003eThe bacteriostatic water should be drawn into a sterile syringe and injected slowly down the inside wall of the lyophilised vial, allowing the peptide cake to dissolve passively rather than through agitation. Tesamorelin is sensitive to heat and freeze-thaw cycling; reconstituted stocks should be aliquoted, refrigerated at 2–8°C and protected from light, with research stocks typically used within 30 days.\u003c\/p\u003e\n\n\u003cp\u003eFor dilution maths across alternative volumes, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e. For long-term storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eIn published research and laboratory protocols, tesamorelin is often examined alongside other GH-axis, metabolic and longevity research compounds:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/cjc-1295-no-dac-ipamorelin-10mg\"\u003eCJC-1295 + Ipamorelin\u003c\/a\u003e — GHRH\/GHRP combination commonly co-investigated with tesamorelin in research on the GH-axis and pulsatile GH release.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/aod-9604-5mg\"\u003eAOD-9604\u003c\/a\u003e — GH fragment studied alongside tesamorelin in adipose tissue and lipolysis research models.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/reta-10mg-15mg-20mg-30mg\"\u003eRetatrutide\u003c\/a\u003e — GLP-1\/GIP\/glucagon triple agonist examined in parallel with tesamorelin in metabolic and visceral adiposity research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/mots-c-10mg-40mg\"\u003eMOTS-c\u003c\/a\u003e — mitochondrial-derived peptide investigated for metabolic and energy-balance effects alongside GH-axis research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/nad-1000mg\"\u003eNAD+\u003c\/a\u003e — co-investigated in metabolic and longevity research alongside GH-axis modulation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader context on combined research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs tesamorelin legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eTesamorelin is not currently registered with the Therapeutic Goods Administration (TGA) for any therapeutic indication in Australia. Optic Labs supplies tesamorelin strictly as a research chemical for in vitro and preclinical laboratory research — not for human consumption, clinical use or any therapeutic application. For a full overview of how the TGA treats research peptides in Australia, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003epeptide legality and TGA compliance guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is tesamorelin?\u003c\/h3\u003e\n\u003cp\u003eTesamorelin is a synthetic 44-amino-acid analogue of human growth hormone-releasing hormone (GHRH 1–44), modified at the N-terminus with a trans-3-hexenoyl group that resists enzymatic degradation. In published research it stimulates pulsatile endogenous GH release through the GHRH receptor on pituitary somatotrophs. For a plain-language overview of peptides, see our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat does tesamorelin do in published research?\u003c\/h3\u003e\n\u003cp\u003eIn published clinical and preclinical research, tesamorelin is studied for its effects on endogenous GH pulse amplitude, IGF-1 levels, visceral adipose tissue volume, hepatic fat fraction and a range of metabolic markers including triglycerides and adiponectin. These observations are research findings only and do not constitute therapeutic claims.\u003c\/p\u003e\n\n\u003ch3\u003eHow does tesamorelin compare with CJC-1295 in research?\u003c\/h3\u003e\n\u003cp\u003eBoth tesamorelin and CJC-1295 are GHRH analogues, but they differ in design.\u003c\/p\u003e\n\n\u003cp\u003eTesamorelin is the full GHRH 1–44 sequence with an N-terminal trans-3-hexenoyl modification for DPP-IV resistance and is supported by the largest published clinical research dataset of any GHRH analogue. \u003ca href=\"\/products\/cjc-1295-no-dac-ipamorelin-10mg\"\u003eCJC-1295 (no DAC)\u003c\/a\u003e is a shorter GHRH 1–29 analogue with several amino acid substitutions for stability, and is most often studied in combination with a ghrelin-receptor agonist such as ipamorelin.\u003c\/p\u003e\n\n\u003ch3\u003eHow is tesamorelin supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies tesamorelin as a lyophilised powder in 10mg glass research vials. Each vial is sealed with a tamper-evident closure. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a 10mg tesamorelin vial?\u003c\/h3\u003e\n\u003cp\u003eFor a 10mg vial, 2ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a 5mg\/ml working stock; 1ml yields a 10mg\/ml stock; 5ml yields a 2mg\/ml stock. Choose a volume based on the concentrations required by the research protocol. For a worked example with unit conversions, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted tesamorelin be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted tesamorelin should be stored at 2–8°C, protected from light, and used within approximately 30 days. For longer-term storage, aliquoting and freezing at −20°C or below is preferred to limit freeze-thaw degradation. Full handling protocols are covered in our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease.\u003c\/p\u003e\n\n\u003cp\u003eOptic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884089016,"sku":null,"price":142.99,"currency_code":"AUD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/tesa10.png?v=1776426119"},{"product_id":"ss-31-10mg","title":"SS-31 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity SS-31 in Australia (10mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout SS-31\u003c\/h2\u003e\n\u003cp\u003eSS-31 (also known as elamipretide, MTP-131 or Bendavia) is a small mitochondria-targeted tetrapeptide developed in the laboratory of Hazel Szeto and Peter Schiller. The sequence — D-Arg-2',6'-dimethylTyr-Lys-Phe-NH\u003csub\u003e2\u003c\/sub\u003e — is engineered to selectively concentrate in the inner mitochondrial membrane, where it associates with cardiolipin and has been characterised for its effects on electron-transport efficiency, reactive oxygen species and ATP production in published research.\u003c\/p\u003e\n\n\u003cp\u003eSS-31 has become one of the most widely cited tools in mitochondrial-protection research over the past decade.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies SS-31 in Australia as a lyophilised powder, 10mg per vial, third-party HPLC verified at \u0026gt;99% purity. The compound is provided strictly for laboratory research, including in-vitro mitochondrial function assays, cell-culture oxidative-stress models and animal studies of cardiac, renal, neurological and ageing biology. SS-31 is supplied for research use only and is not intended for human consumption, clinical, cosmetic, diagnostic or veterinary application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e SS-31 (elamipretide, MTP-131)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 736992-21-5\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e32\u003c\/sub\u003eH\u003csub\u003e49\u003c\/sub\u003eN\u003csub\u003e9\u003c\/sub\u003eO\u003csub\u003e5\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~639.8 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e D-Arg-Dmt-Lys-Phe-NH\u003csub\u003e2\u003c\/sub\u003e (D-Arg-2',6'-dimethylTyr-Lys-Phe amide)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eSS-31 was first described in the early 2000s as part of the Szeto-Schiller (SS) series of cell-permeable, mitochondria-targeted antioxidant peptides. Unlike triphenylphosphonium-conjugated antioxidants, SS-31 concentrates in the inner mitochondrial membrane independent of membrane potential, where it interacts with cardiolipin. This pharmacophore has driven a sustained body of preclinical and clinical research into mitochondrial dysfunction.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eCardiolipin binding and stabilisation of inner-mitochondrial-membrane cristae architecture in isolated mitochondria and cell-culture models.\u003c\/li\u003e\n\u003cli\u003eReductions in mitochondrial reactive oxygen species (ROS) generation and improved electron-transport-chain coupling in ischaemia-reperfusion models.\u003c\/li\u003e\n\u003cli\u003eCardioprotection in rodent models of myocardial infarction, heart failure and doxorubicin-induced cardiotoxicity.\u003c\/li\u003e\n\u003cli\u003eRenal-protection studies in models of acute kidney injury, ischaemia-reperfusion and chronic kidney disease.\u003c\/li\u003e\n\u003cli\u003eNeuroprotective signals in animal models of Parkinson's disease, traumatic brain injury and age-related cognitive decline.\u003c\/li\u003e\n\u003cli\u003eSkeletal-muscle research in ageing and disuse-atrophy models examining mitochondrial bioenergetics and fatigue resistance.\u003c\/li\u003e\n\u003cli\u003eInvestigation in primary mitochondrial diseases including Barth syndrome and mitochondrial myopathies through clinical research programmes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader mitochondrial-research context, see our \u003ca href=\"\/blogs\/news\/ss-31-mitochondrial-protection-research-guide\"\u003eSS-31 mitochondrial protection research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/mots-c-mitochondrial-peptide-longevity-research\"\u003eMOTS-c mitochondrial peptide guide\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eSS-31 is supplied lyophilised and should be reconstituted with sterile \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e for laboratory use. A common working approach is to add 2mL of bacteriostatic water to a 10mg vial, yielding a 5mg\/mL stock; 1mL gives 10mg\/mL for more concentrated workflows.\u003c\/p\u003e\n\n\u003cp\u003eAdd the diluent slowly down the side of the vial — do not inject directly onto the lyophilised cake — and allow the powder to dissolve without vigorous shaking. Reconstituted SS-31 should be stored at 2–8°C, protected from light, and used within 30 days.\u003c\/p\u003e\n\n\u003cp\u003eFor a step-by-step volume calculator and worked examples for any vial size, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution calculator guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eSS-31 is frequently studied alongside other peptides relevant to mitochondrial function, longevity and tissue-repair pathways:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/mots-c-10mg-40mg\"\u003eMOTS-c\u003c\/a\u003e — mitochondrial-derived peptide examined in metabolic and exercise-mimetic research, complementary to SS-31 in mitochondrial-bioenergetics studies.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/nad-1000mg\"\u003eNAD+\u003c\/a\u003e — coenzyme central to electron transport and sirtuin signalling; commonly paired in mitochondrial-longevity research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/epithalong-10mg\"\u003eEpithalon\u003c\/a\u003e — AEDG tetrapeptide investigated in telomerase and ageing-biology models.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glutathione-1500mg\"\u003eGlutathione\u003c\/a\u003e — endogenous antioxidant tripeptide, often used as a reference compound in oxidative-stress assays.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ghk-cu-50mg-100mg\"\u003eGHK-Cu\u003c\/a\u003e — copper-binding tripeptide studied in mitochondrial-gene-expression and tissue-regeneration research.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader stack-design context, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs SS-31 legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eSS-31 is not an approved therapeutic good in Australia and is not registered with the Therapeutic Goods Administration (TGA). Optic Labs supplies SS-31 strictly for laboratory research, development and analytical use — not for human consumption, clinical or cosmetic application. For a detailed overview of how research peptides sit within the Australian regulatory framework, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is SS-31?\u003c\/h3\u003e\n\u003cp\u003eSS-31 is a synthetic mitochondria-targeted tetrapeptide (D-Arg-Dmt-Lys-Phe-NH\u003csub\u003e2\u003c\/sub\u003e), also known as elamipretide or MTP-131. It is one of the Szeto-Schiller series of peptides developed to concentrate in the inner mitochondrial membrane and interact with cardiolipin. For a plain-language overview of peptide structure and research use, see our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eHow does SS-31 differ from MOTS-c in mitochondrial research?\u003c\/h3\u003e\n\u003cp\u003eBoth compounds are studied in mitochondrial-function research but operate differently. SS-31 is a synthetic, mitochondria-targeted tetrapeptide that concentrates at cardiolipin in the inner mitochondrial membrane and is investigated for effects on cristae architecture, ROS and electron transport.\u003c\/p\u003e\n\n\u003cp\u003eMOTS-c is a mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA, studied as a metabolic regulator that signals to the nucleus. Researchers often examine the two in parallel rather than as substitutes — see our \u003ca href=\"\/blogs\/news\/mots-c-mitochondrial-peptide-longevity-research\"\u003eMOTS-c research guide\u003c\/a\u003e for context.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with an SS-31 10mg vial?\u003c\/h3\u003e\n\u003cp\u003eFor a 10mg vial, 2mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e gives a 5mg\/mL stock; 1mL gives 10mg\/mL. Choose the dilution that matches the volumes typical of your research protocol. See our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e for worked examples.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted SS-31 be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted SS-31 should be stored at 2–8°C, protected from light, and used within 30 days. Lyophilised vials are stable at 2–8°C until reconstitution. For full handling guidance, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease.\u003c\/p\u003e\n\n\u003cp\u003eOptic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884121784,"sku":null,"price":61.99,"currency_code":"AUD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/ss31.png?v=1776426119"},{"product_id":"semax-10mg","title":"Semax 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity semax (10mg) in Australia. Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout semax\u003c\/h2\u003e\n\u003cp\u003eSemax is a synthetic heptapeptide developed at the Russian Academy of Sciences and the Institute of Molecular Genetics in the late 1980s. Its sequence (Met-Glu-His-Phe-Pro-Gly-Pro) is a fragment analogue of the N-terminal of adrenocorticotropic hormone (ACTH 4–7), modified with a C-terminal Pro-Gly-Pro tripeptide that markedly extends its plasma stability. In published research, semax is one of the most extensively studied nootropic and neuroprotective research peptides in the Russian and Eastern European scientific literature, with research interest in its effects on brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF) and the dopaminergic and serotonergic systems.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies semax as a lyophilised powder in 10mg research vials, third-party HPLC tested to \u0026gt;99% purity. The product is distributed Australian-domestic from Sydney, NSW, for in vitro and laboratory research applications. Semax is supplied strictly for laboratory research, development or analytical use and is not intended for human consumption.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Semax (ACTH 4–7 PGP analogue)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 80714-61-0\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e37\u003c\/sub\u003eH\u003csub\u003e51\u003c\/sub\u003eN\u003csub\u003e9\u003c\/sub\u003eO\u003csub\u003e10\u003c\/sub\u003eS\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~813.93 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e Met-Glu-His-Phe-Pro-Gly-Pro\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable size:\u003c\/strong\u003e 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eSemax was developed by Russian researchers as a non-hormonal analogue of ACTH 4–10, retaining behavioural and neurotrophic activity while removing corticotropic effects. The C-terminal Pro-Gly-Pro extension provides resistance to enzymatic degradation, which gives semax an unusually long functional half-life for a small peptide. Semax is registered as a medicine in the Russian Federation but, in the Australian and Western research context, it is studied as a research-use compound.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBDNF and neurotrophic signalling:\u003c\/strong\u003e in rodent brain-tissue research, semax administration has been associated with rapid increases in BDNF and NGF expression, particularly in the hippocampus and basal forebrain.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCognitive performance models:\u003c\/strong\u003e in animal models of learning and memory, semax has been investigated for effects on attention, working memory and behavioural flexibility under cognitive load.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCerebral ischaemia research:\u003c\/strong\u003e in rodent stroke and middle cerebral artery occlusion (MCAO) models, semax has been studied as a neuroprotective candidate, with research interest in infarct volume, oxidative stress markers and neurological recovery.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDopaminergic and serotonergic modulation:\u003c\/strong\u003e in receptor-binding and microdialysis studies, semax has been examined for modulation of dopamine and serotonin turnover in striatal and cortical tissue.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEnkephalin system interactions:\u003c\/strong\u003e in published research, semax administration has been associated with elevated enkephalin levels, providing a candidate mechanism for some of its anxiolytic-like effects in animal models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAntioxidant gene expression:\u003c\/strong\u003e in cell-culture and brain-tissue studies, semax has been associated with up-regulation of genes involved in cellular antioxidant defence.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePharmacokinetic stability:\u003c\/strong\u003e in published research, the Pro-Gly-Pro modification gives semax substantially longer functional activity than the parent ACTH 4–10 fragment, supporting its position as one of the more practically usable nootropic research peptides.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary, see our \u003ca href=\"\/blogs\/news\/semax-australia-nootropic-research-guide\"\u003esemax nootropic research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eSemax is highly water-soluble and reconstitutes readily. A common laboratory approach for the 10mg vial is reconstitution in 2ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e to yield a 5mg\/ml working stock, or in 1ml for a 10mg\/ml stock. The bacteriostatic water should be drawn into a sterile syringe and injected slowly down the inside wall of the lyophilised vial, allowing the peptide cake to dissolve passively rather than through agitation. Reconstituted semax should be aliquoted, refrigerated at 2–8°C and protected from light, with research stocks typically used within 30 days. For dilution maths across alternative volumes, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e. For long-term storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eIn published research and laboratory protocols, semax is often examined alongside other nootropic, anxiolytic and longevity research compounds:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/selank-10mg\"\u003eSelank\u003c\/a\u003e — anxiolytic heptapeptide developed by the same research group; commonly co-investigated with semax in stress and cognitive performance models.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/dsip-10mg-15mg\"\u003eDSIP\u003c\/a\u003e — delta sleep-inducing peptide examined alongside semax in studies of sleep architecture and stress recovery.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/nad-1000mg\"\u003eNAD+\u003c\/a\u003e — co-investigated in neuronal energetics and longevity research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/epithalong-10mg\"\u003eEpithalon\u003c\/a\u003e — telomere and longevity research peptide commonly grouped with semax in anti-ageing study designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/mots-c-10mg-40mg\"\u003eMOTS-c\u003c\/a\u003e — mitochondrial-derived peptide examined in parallel with semax in research on neuronal energy metabolism.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader context on combined research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs semax legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eSemax is not a scheduled substance under the Australian Poisons Standard, but it is also not registered as a therapeutic good in Australia. Optic Labs supplies semax strictly for laboratory, research and analytical use only, not as a therapeutic good. For a full overview of how the Therapeutic Goods Administration treats research peptides in Australia, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003epeptide legality and TGA compliance guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is semax?\u003c\/h3\u003e\n\u003cp\u003eSemax is a synthetic heptapeptide analogue of ACTH 4–7, modified with a C-terminal Pro-Gly-Pro tripeptide for enzymatic stability. It is one of the most extensively studied nootropic research peptides in Russian and Eastern European scientific literature. For a plain-language overview of peptides, see our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat does semax do in published research?\u003c\/h3\u003e\n\u003cp\u003eIn published research, semax is studied for its effects on BDNF and NGF expression, dopaminergic and serotonergic neurotransmission, cerebral ischaemia outcomes in rodent stroke models, and cognitive performance in animal models of learning and memory. These observations are research findings only and do not constitute therapeutic claims. For a research-level summary, see our \u003ca href=\"\/blogs\/news\/semax-australia-nootropic-research-guide\"\u003esemax nootropic research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eHow does semax compare with selank in research?\u003c\/h3\u003e\n\u003cp\u003eSemax and selank were both developed by the same Russian research group as Pro-Gly-Pro-stabilised heptapeptides, but they target distinct research areas. Semax is primarily examined for nootropic and neuroprotective effects via the BDNF\/NGF axis. \u003ca href=\"\/products\/selank-10mg\"\u003eSelank\u003c\/a\u003e is more often investigated for anxiolytic-like effects via GABAergic and tuftsin-related pathways. The two are frequently co-studied in stress and cognitive performance models.\u003c\/p\u003e\n\n\u003ch3\u003eHow is semax supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies semax as a lyophilised powder in 10mg glass research vials. Each vial is sealed with a tamper-evident closure. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a 10mg semax vial?\u003c\/h3\u003e\n\u003cp\u003eFor a 10mg vial, 2ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a 5mg\/ml working stock; 1ml yields a 10mg\/ml stock; 5ml yields a 2mg\/ml stock. Choose a volume based on the concentrations required by the research protocol. For a worked example with unit conversions, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted semax be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted semax should be stored at 2–8°C, protected from light, and used within approximately 30 days. For longer-term storage, aliquoting and freezing at −20°C or below is preferred to limit freeze-thaw degradation. Full handling protocols are covered in our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884220088,"sku":null,"price":61.99,"currency_code":"AUD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/semax.png?v=1776426119"},{"product_id":"selank-10mg","title":"Selank 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity selank (10mg) in Australia. Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout selank\u003c\/h2\u003e\n\u003cp\u003eSelank is a synthetic heptapeptide developed at the Russian Academy of Sciences and the Institute of Molecular Genetics in the early 1990s. Its sequence (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is an analogue of the endogenous immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg), extended with the C-terminal Pro-Gly-Pro tripeptide that the same research group used to stabilise \u003ca href=\"\/products\/semax-10mg\"\u003esemax\u003c\/a\u003e. The Pro-Gly-Pro modification confers strong resistance to enzymatic degradation, giving selank an unusually long functional half-life for a small peptide. In published research, selank is one of the most extensively studied anxiolytic and immunomodulatory research peptides in the Russian and Eastern European scientific literature, with research interest in GABAergic transmission, BDNF and tuftsin-like immune signalling.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies selank as a lyophilised powder in 10mg research vials, third-party HPLC tested to \u0026gt;99% purity. The product is distributed Australian-domestic from Sydney, NSW, for in vitro and laboratory research applications. Selank is supplied strictly for laboratory research, development or analytical use and is not intended for human consumption.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Selank (tuftsin-PGP analogue)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 129954-34-3\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e33\u003c\/sub\u003eH\u003csub\u003e57\u003c\/sub\u003eN\u003csub\u003e11\u003c\/sub\u003eO\u003csub\u003e9\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~751.86 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e Thr-Lys-Pro-Arg-Pro-Gly-Pro (heptapeptide)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable size:\u003c\/strong\u003e 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eSelank was developed by the same Russian research group that produced semax, with the explicit aim of generating a stable analogue of the immunomodulatory tetrapeptide tuftsin. Tuftsin itself is rapidly degraded in plasma; appending the Pro-Gly-Pro extension produced a peptide with substantially extended functional activity while retaining tuftsin-like binding properties. Selank is registered as a medicine in the Russian Federation but, in the Australian and Western research context, it is studied as a research-use compound.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGABAergic transmission:\u003c\/strong\u003e in published rodent research, selank has been investigated for effects on the GABA-A receptor system and on benzodiazepine-like anxiolytic-type behavioural readouts in elevated-plus-maze and open-field paradigms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBDNF and neurotrophic signalling:\u003c\/strong\u003e in brain-tissue research, selank administration has been associated with changes in BDNF expression in the hippocampus, providing a candidate mechanism for its observed effects on stress-related behavioural models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTuftsin-like immunomodulation:\u003c\/strong\u003e in cell-culture and animal-model studies, selank retains tuftsin-like activity at receptors expressed on macrophages and other immune cells, with research interest in cytokine balance and innate immune responses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEnkephalin system interactions:\u003c\/strong\u003e in published research, selank has been associated with elevated plasma and central enkephalin levels, paralleling the enkephalin-related findings reported for semax.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStress and anxiety models:\u003c\/strong\u003e in rodent research, selank has been examined in models of acute and chronic stress, with research interest in the behavioural correlates of anxiety and the molecular signatures of stress-axis activation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCognitive performance research:\u003c\/strong\u003e in animal models of learning and memory, selank has been investigated for effects on attention, working memory and behavioural flexibility, often in combination with semax.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePharmacokinetic stability:\u003c\/strong\u003e in published research, the Pro-Gly-Pro modification gives selank substantially longer functional activity than the parent tuftsin tetrapeptide, supporting its position as one of the more practically usable anxiolytic research peptides.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary, see our \u003ca href=\"\/blogs\/news\/selank-australia-anxiolytic-research-guide\"\u003eselank anxiolytic research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eSelank is highly water-soluble and reconstitutes readily. A common laboratory approach for the 10mg vial is reconstitution in 2ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e to yield a 5mg\/ml working stock, or in 1ml for a 10mg\/ml stock. The bacteriostatic water should be drawn into a sterile syringe and injected slowly down the inside wall of the lyophilised vial, allowing the peptide cake to dissolve passively rather than through agitation. Reconstituted selank should be aliquoted, refrigerated at 2–8°C and protected from light, with research stocks typically used within 30 days. For dilution maths across alternative volumes, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e. For long-term storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eIn published research and laboratory protocols, selank is often examined alongside other nootropic, anxiolytic and central-nervous-system research compounds:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/semax-10mg\"\u003eSemax\u003c\/a\u003e — nootropic heptapeptide developed by the same Russian research group; commonly co-investigated with selank in stress and cognitive performance models.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/dsip-10mg-15mg\"\u003eDSIP\u003c\/a\u003e — delta sleep-inducing peptide examined alongside selank in studies of sleep architecture, anxiety and stress recovery.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/pt-141-10mg\"\u003ePT-141\u003c\/a\u003e — MC4R-preferring melanocortin agonist co-investigated with selank in central nervous system and behavioural research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/epithalong-10mg\"\u003eEpithalon\u003c\/a\u003e — telomere and longevity research peptide commonly grouped with selank in anti-ageing study designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/nad-1000mg\"\u003eNAD+\u003c\/a\u003e — co-investigated in neuronal energetics and longevity research alongside selank.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader context on combined research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs selank legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eSelank is not a scheduled substance under the Australian Poisons Standard, but it is also not registered as a therapeutic good in Australia. Optic Labs supplies selank strictly for laboratory, research and analytical use only, not as a therapeutic good. For a full overview of how the Therapeutic Goods Administration treats research peptides in Australia, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003epeptide legality and TGA compliance guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is selank?\u003c\/h3\u003e\n\u003cp\u003eSelank is a synthetic heptapeptide analogue of the immunomodulatory tetrapeptide tuftsin, extended with a C-terminal Pro-Gly-Pro group for enzymatic stability. It is one of the most extensively studied anxiolytic and immunomodulatory research peptides in Russian and Eastern European scientific literature. For more detail, see our \u003ca href=\"\/blogs\/news\/selank-australia-anxiolytic-research-guide\"\u003eselank anxiolytic research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat does selank do in published research?\u003c\/h3\u003e\n\u003cp\u003eIn published research, selank is studied for its effects on GABAergic transmission, hippocampal BDNF expression, tuftsin-like immune cell signalling, central enkephalin levels, and behavioural readouts in rodent stress and anxiety models. These observations are research findings only and do not constitute therapeutic claims. For a research-level summary, see our \u003ca href=\"\/blogs\/news\/selank-australia-anxiolytic-research-guide\"\u003eselank research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eHow does selank compare with semax in research?\u003c\/h3\u003e\n\u003cp\u003eSelank and \u003ca href=\"\/products\/semax-10mg\"\u003esemax\u003c\/a\u003e were both developed by the same Russian research group as Pro-Gly-Pro-stabilised heptapeptides, but they target distinct research areas. Selank is primarily examined for anxiolytic-like and immunomodulatory effects via the GABAergic and tuftsin-related pathways. Semax is more often investigated for nootropic and neuroprotective effects via the BDNF\/NGF axis. The two are frequently co-studied in stress and cognitive performance models.\u003c\/p\u003e\n\n\u003ch3\u003eHow is selank supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies selank as a lyophilised powder in 10mg glass research vials. Each vial is sealed with a tamper-evident closure. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a 10mg selank vial?\u003c\/h3\u003e\n\u003cp\u003eFor a 10mg vial, 2ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a 5mg\/ml working stock; 1ml yields a 10mg\/ml stock; 5ml yields a 2mg\/ml stock. Choose a volume based on the concentrations required by the research protocol. For a worked example with unit conversions, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted selank be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted selank should be stored at 2–8°C, protected from light, and used within approximately 30 days. For longer-term storage, aliquoting and freezing at −20°C or below is preferred to limit freeze-thaw degradation. Full handling protocols are covered in our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884252856,"sku":null,"price":56.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/selank.png?v=1776426119"},{"product_id":"pt-141-10mg","title":"PT-141 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity PT-141 (10mg) in Australia. Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout PT-141\u003c\/h2\u003e\n\u003cp\u003ePT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide melanocortin receptor agonist developed at Palatin Technologies in the early 2000s as a structurally optimised analogue of \u003ca href=\"\/products\/melanotan-2-10mg\"\u003eMelanotan-2\u003c\/a\u003e. By removing the C-terminal lysine amide of MT-2 and retaining the cyclic Asp-Lys lactam bridge, PT-141 was engineered to preferentially activate the central melanocortin-4 receptor (MC4R) while reducing activity at MC1R and the associated melanogenic effects.\u003c\/p\u003e\n\n\u003cp\u003eIn published research, PT-141 has become one of the most extensively characterised MC4R-preferring research peptides, with study interest concentrated on central nervous system pathways relevant to sexual function and the broader pharmacology of the MC3R\/MC4R subtypes.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies PT-141 as a lyophilised powder in 10mg research vials, third-party HPLC tested to \u0026gt;99% purity. The product is distributed Australian-domestic from Sydney, NSW, for in vitro and laboratory research applications. PT-141 is supplied strictly for laboratory research, development or analytical use and is not intended for human consumption.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e PT-141 (bremelanotide)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 189691-06-3\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e50\u003c\/sub\u003eH\u003csub\u003e68\u003c\/sub\u003eN\u003csub\u003e14\u003c\/sub\u003eO\u003csub\u003e10\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~1025.16 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH (cyclic heptapeptide)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable size:\u003c\/strong\u003e 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003ePT-141 was developed by Palatin Technologies as a follow-on to the University of Arizona's MT-2 research programme. Where MT-2 is a non-selective pan-melanocortin agonist, PT-141 was engineered through C-terminal modification to retain MC4R activity while reducing the MC1R-mediated melanogenic effects.\u003c\/p\u003e\n\n\u003cp\u003eThe compound has been characterised extensively in receptor pharmacology, behavioural neuroscience and clinical research, and was approved by the US FDA in 2019 under the trade name Vyleesi for hypoactive sexual desire disorder in premenopausal women — making it the most clinically validated melanocortin research peptide currently available.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMC4R-preferring receptor pharmacology:\u003c\/strong\u003e in receptor-binding and cAMP accumulation assays, PT-141 acts as an agonist at MC3R and MC4R with reduced relative activity at MC1R compared with MT-2, supporting its use as a research tool for probing MC4R-specific signalling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCentral pathways of sexual behaviour:\u003c\/strong\u003e in published rodent and primate research, MC4R activation in the medial preoptic area and paraventricular nucleus has been investigated as a central mechanism for proceptive and consummatory sexual behaviour, with PT-141 used as the principal MC4R-preferring research probe.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypothalamic signalling:\u003c\/strong\u003e in animal-model research, PT-141 has been examined for its effects on hypothalamic dopamine and oxytocin release, providing a candidate downstream mechanism for its observed behavioural effects.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiovascular research:\u003c\/strong\u003e in published clinical and preclinical research, MC4R activation has been studied for effects on blood pressure and heart rate, with PT-141 used as a tool to characterise the magnitude and time course of these responses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEnergy balance research:\u003c\/strong\u003e in rodent hypothalamic studies, MC4R activation has been examined for effects on food intake and body weight in animal models, building on the genetic literature linking MC4R to energy homeostasis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComparative melanocortin pharmacology:\u003c\/strong\u003e PT-141 is widely used alongside MT-2, NDP-α-MSH and selective MC4R antagonists in research designs comparing the contributions of each melanocortin subtype to a given functional outcome.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInflammation research:\u003c\/strong\u003e in cell-culture studies, MC3R\/MC4R-preferring agonists have been examined for anti-inflammatory and immunomodulatory effects, complementing the MC1R-focused inflammation literature.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a plain-language overview of peptides, see our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e, and for laboratory injection protocols our \u003ca href=\"\/blogs\/news\/how-to-inject-peptides-subcutaneous-protocol\"\u003esubcutaneous injection protocol article\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003ePT-141 is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use in any laboratory protocol. A common laboratory approach for the 10mg vial is reconstitution in 2ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e to yield a 5mg\/ml working stock, or in 1ml for a 10mg\/ml stock.\u003c\/p\u003e\n\n\u003cp\u003eThe bacteriostatic water should be drawn into a sterile syringe and injected slowly down the inside wall of the lyophilised vial, allowing the peptide cake to dissolve passively rather than through agitation. Reconstituted PT-141 should be aliquoted, refrigerated at 2–8°C and protected from light, with research stocks typically used within 30 days.\u003c\/p\u003e\n\n\u003cp\u003eFor dilution maths across alternative volumes, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e. For long-term storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eIn published research and laboratory protocols, PT-141 is examined alongside other melanocortin and central-nervous-system research compounds:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/melanotan-2-10mg\"\u003eMelanotan-2\u003c\/a\u003e — non-selective melanocortin agonist studied alongside PT-141 to dissect MC1R versus MC4R contributions to a given research outcome.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/selank-10mg\"\u003eSelank\u003c\/a\u003e — anxiolytic heptapeptide co-investigated with PT-141 in central nervous system and stress-axis research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/semax-10mg\"\u003eSemax\u003c\/a\u003e — nootropic peptide examined alongside PT-141 in studies probing dopaminergic and central neurotransmitter pathways.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/dsip-10mg-15mg\"\u003eDSIP\u003c\/a\u003e — delta sleep-inducing peptide co-studied in research on central regulation of arousal and behaviour.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/cjc-1295-no-dac-ipamorelin-10mg\"\u003eCJC-1295 + Ipamorelin\u003c\/a\u003e — GH-axis research blend examined in parallel with PT-141 in studies of hypothalamic peptide signalling.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader context on combined research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs PT-141 legal in Australia?\u003c\/h3\u003e\n\u003cp\u003ePT-141 (bremelanotide) is not currently registered with the Therapeutic Goods Administration (TGA) for any therapeutic indication in Australia, even though the compound has been approved in some other jurisdictions. Optic Labs supplies PT-141 strictly as a research chemical for in vitro and preclinical laboratory research — not for human consumption, clinical use or any therapeutic application.\u003c\/p\u003e\n\n\u003cp\u003eFor a full overview of how the TGA treats research peptides in Australia, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003epeptide legality and TGA compliance guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is PT-141?\u003c\/h3\u003e\n\u003cp\u003ePT-141 is a synthetic cyclic heptapeptide melanocortin receptor agonist with preferential activity at MC4R. It was developed at Palatin Technologies as an MC4R-preferring analogue of \u003ca href=\"\/products\/melanotan-2-10mg\"\u003eMelanotan-2\u003c\/a\u003e, with reduced activity at the pigmentation-related MC1R subtype. For a plain-language overview of peptides, see our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat does PT-141 do in published research?\u003c\/h3\u003e\n\u003cp\u003eIn published research, PT-141 is studied for its effects on MC3R\/MC4R receptor signalling, central nervous system pathways relevant to sexual behaviour, hypothalamic dopamine and oxytocin release, cardiovascular parameters such as blood pressure, and food intake regulation in rodent models. These observations are research findings only and do not constitute therapeutic claims.\u003c\/p\u003e\n\n\u003ch3\u003eHow does PT-141 compare with Melanotan-2 in research?\u003c\/h3\u003e\n\u003cp\u003ePT-141 and \u003ca href=\"\/products\/melanotan-2-10mg\"\u003eMelanotan-2\u003c\/a\u003e share the same cyclic Asp-Lys core. PT-141 differs in that the C-terminal residue is a free carboxylate rather than a lysine amide, which biases its activity toward MC4R and away from MC1R. In research settings PT-141 is used as the more MC4R-selective probe, while MT-2 is used when broad melanocortin agonism is required.\u003c\/p\u003e\n\n\u003ch3\u003eHow is PT-141 supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies PT-141 as a lyophilised powder in 10mg glass research vials. Each vial is sealed with a tamper-evident closure. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a 10mg PT-141 vial?\u003c\/h3\u003e\n\u003cp\u003eFor a 10mg vial, 2ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a 5mg\/ml working stock; 1ml yields a 10mg\/ml stock; 5ml yields a 2mg\/ml stock. Choose a volume based on the concentrations required by the research protocol. For a worked example with unit conversions, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted PT-141 be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted PT-141 should be stored at 2–8°C, protected from light, and used within approximately 30 days. For longer-term storage, aliquoting and freezing at −20°C or below is preferred to limit freeze-thaw degradation. Full handling protocols are covered in our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease.\u003c\/p\u003e\n\n\u003cp\u003eOptic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884285624,"sku":null,"price":61.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/pt141_a825478f-65ca-4ebe-b9d0-4218d306ff8e.png?v=1776428883"},{"product_id":"nad-1000mg","title":"NAD+ 1000mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity NAD+ in Australia (1000mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout NAD+\u003c\/h2\u003e\n\u003cp\u003eNAD+ (Nicotinamide Adenine Dinucleotide) is a fundamental redox coenzyme found in every living cell. It plays an essential role in cellular energy metabolism, mitochondrial function, sirtuin and PARP signalling, and DNA repair. Optic Labs supplies NAD+ as a high-purity lyophilised powder in 1000mg (1g) vials, packaged for in vitro and preclinical laboratory research. Each batch is independently HPLC-tested for purity and identity, with certificates of analysis available on request.\u003c\/p\u003e\n\n\u003cp\u003eNAD+ has become one of the most studied molecules in the longevity, mitochondrial biology and metabolic research literature. Published research has investigated NAD+ in models of cellular ageing, sirtuin activation, NAD+\/NADH ratio regulation, axonal protection and mitochondrial bioenergetics. Optic Labs supplies the compound for laboratory research only — not for human consumption, clinical use, or any therapeutic application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e NAD+ (β-Nicotinamide Adenine Dinucleotide)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 53-84-9\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e21\u003c\/sub\u003eH\u003csub\u003e27\u003c\/sub\u003eN\u003csub\u003e7\u003c\/sub\u003eO\u003csub\u003e14\u003c\/sub\u003eP\u003csub\u003e2\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~663.43 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised (freeze-dried) white-to-off-white powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable size:\u003c\/strong\u003e 1000mg (1g) vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store unreconstituted vials at 2–8°C; protect from light. Reconstituted solution stored at 2–8°C and used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eNAD+ was first identified by Harden and Young in 1906 as a \"co-ferment\" required for yeast fermentation. The molecule's central role in cellular metabolism has driven extensive published research across multiple decades, including:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSirtuin (SIRT1-7) deacetylase activation and gene expression regulation\u003c\/li\u003e\n\u003cli\u003ePARP (poly-ADP-ribose polymerase) DNA repair pathways\u003c\/li\u003e\n\u003cli\u003eMitochondrial NAD+\/NADH ratio and oxidative phosphorylation\u003c\/li\u003e\n\u003cli\u003eCD38 hydrolase and NAD+ consumption pathways\u003c\/li\u003e\n\u003cli\u003eWallerian degeneration and axonal protection studies\u003c\/li\u003e\n\u003cli\u003eCellular senescence and longevity-pathway research\u003c\/li\u003e\n\u003cli\u003eMetabolic disease models — NAFLD, insulin sensitivity research\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary with study citations, see our \u003ca href=\"\/blogs\/news\/nad-plus-australia-longevity-research-guide\"\u003eNAD+ longevity research guide\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eNAD+ is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use in any laboratory protocol. A 1000mg vial reconstituted in 5mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a working concentration of 200mg\/mL; in 10mL it yields 100mg\/mL. NAD+ is light-sensitive and pH-sensitive, so reconstituted solutions should be stored refrigerated at 2–8°C, protected from light, and used within approximately 30 days. Our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e walks through the maths.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eNAD+ is frequently studied alongside other longevity and mitochondrial-research peptides. Researchers may also be interested in:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/mots-c-10mg-40mg\"\u003eMOTS-c\u003c\/a\u003e — mitochondrial-derived peptide research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ss-31-10mg\"\u003eSS-31\u003c\/a\u003e — mitochondrial protection research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/epithalong-10mg\"\u003eEpithalon\u003c\/a\u003e — telomerase and longevity research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/5-amino-1mq-10mg\"\u003e5-Amino-1MQ\u003c\/a\u003e — NNMT inhibition and metabolic research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glutathione-1500mg\"\u003eGlutathione\u003c\/a\u003e — antioxidant defence research\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs NAD+ legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eNAD+ as a research chemical is not currently approved by the Therapeutic Goods Administration (TGA) for therapeutic use in Australia. Optic Labs supplies NAD+ strictly as a research chemical for in vitro and preclinical laboratory research — not for human consumption, clinical use or any therapeutic application. For a detailed overview, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is NAD+?\u003c\/h3\u003e\n\u003cp\u003eNAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells, central to cellular metabolism, mitochondrial function and DNA repair. In published research it has been investigated for its role in sirtuin activation, NAD+\/NADH ratio regulation and longevity-pathway signalling. See our \u003ca href=\"\/blogs\/news\/nad-plus-australia-longevity-research-guide\"\u003eNAD+ longevity research guide\u003c\/a\u003e for background.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is the difference between NAD+, NADH, NMN and NR?\u003c\/h3\u003e\n\u003cp\u003eNAD+ is the oxidised form of the coenzyme; NADH is its reduced form. NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside) are precursor molecules in the NAD+ biosynthetic salvage pathway. Optic Labs supplies the NAD+ form directly. Our \u003ca href=\"\/blogs\/news\/nad-plus-australia-longevity-research-guide\"\u003eresearch guide\u003c\/a\u003e covers the differences in the published biochemistry literature.\u003c\/p\u003e\n\n\u003ch3\u003eHow is NAD+ supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies NAD+ as a lyophilised powder in glass research vials in a 1000mg (1g) size. Each vial is sealed and shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted NAD+ be stored?\u003c\/h3\u003e\n\u003cp\u003eNAD+ is particularly sensitive to light, heat, and pH. Unreconstituted vials should be stored at 2–8°C and protected from light. Once reconstituted, the solution should be refrigerated at 2–8°C, kept strictly away from light, and used within approximately 30 days. For full storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884318392,"sku":null,"price":81.99,"currency_code":"AUD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/nad_1000_378efd7c-8468-43a4-8161-90415ff14af0.png?v=1776426193"},{"product_id":"mots-c-10mg-40mg","title":"MOTS-C 10mg \/ 40mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity MOTS-c (10mg \/ 40mg) in Australia. Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout MOTS-c\u003c\/h2\u003e\n\u003cp\u003eMOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA-c) is a 16-amino-acid mitochondrial-derived peptide (MDP) encoded within the 12S ribosomal RNA region of mitochondrial DNA. It was identified in 2015 by the Cohen laboratory at the University of Southern California and is one of the founding members of a new class of peptides that exemplify retrograde mitochondrial-to-nuclear signalling. In published research, MOTS-c has rapidly become one of the most studied mitochondrial peptides in metabolic, ageing and exercise biology, with research interest concentrated on AMPK activation, glucose homeostasis, insulin sensitivity and mitochondrial-nuclear cross-talk.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies MOTS-c as a lyophilised powder in 10mg and 40mg research vials, third-party HPLC tested to \u0026gt;99% purity. The product is distributed Australian-domestic from Sydney, NSW, for in vitro and laboratory research applications. MOTS-c is supplied strictly for laboratory research, development or analytical use and is not intended for human consumption.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e MOTS-c (mitochondrial-derived peptide)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 1627580-64-6\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e78\u003c\/sub\u003eH\u003csub\u003e123\u003c\/sub\u003eN\u003csub\u003e21\u003c\/sub\u003eO\u003csub\u003e23\u003c\/sub\u003eS\u003csub\u003e2\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~1791.07 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (16 amino acids)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 10mg vial \/ 40mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eMOTS-c was first characterised by Lee, Cohen and colleagues in 2015, using a bioinformatic approach to scan small open reading frames within mitochondrial DNA. The 12S rRNA-encoded peptide was shown to be biologically active, present in plasma and skeletal muscle, and capable of translocating to the nucleus under metabolic stress to regulate gene expression. The discovery established mitochondrial-derived peptides as a distinct class of regulatory signalling molecules.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAMPK activation:\u003c\/strong\u003e in cell-culture and rodent skeletal muscle research, MOTS-c administration has been associated with activation of AMP-activated protein kinase, a master regulator of cellular energy balance, with downstream effects on glucose uptake and fatty acid oxidation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlucose homeostasis and insulin sensitivity:\u003c\/strong\u003e in published rodent research, MOTS-c has been investigated for effects on insulin-stimulated glucose disposal, hepatic glucose production and whole-body insulin sensitivity in models of diet-induced metabolic dysregulation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMitochondrial-nuclear retrograde signalling:\u003c\/strong\u003e in cellular research, MOTS-c has been shown to translocate to the nucleus under metabolic stress and modulate expression of antioxidant response element (ARE) and other stress-responsive genes through interactions with NRF2 and related transcription factors.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExercise biology:\u003c\/strong\u003e in animal-model research, MOTS-c has been examined as a potential exercise mimetic, with studies reporting changes in running capacity, muscle metabolic gene expression and substrate utilisation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAgeing research:\u003c\/strong\u003e circulating MOTS-c levels have been investigated in published research as candidate biomarkers of mitochondrial function across the lifespan, with studies examining age-related declines in plasma MOTS-c and associations with metabolic phenotypes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBone and adipose tissue research:\u003c\/strong\u003e in cell-culture and animal models, MOTS-c has been studied for effects on osteoblast differentiation and adipocyte metabolism through AMPK-dependent pathways.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiovascular research:\u003c\/strong\u003e exploratory studies have examined MOTS-c in the context of myocardial energetics, ischaemia-reperfusion injury models and vascular function.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary, see our \u003ca href=\"\/blogs\/news\/mots-c-mitochondrial-peptide-longevity-research\"\u003eMOTS-c mitochondrial peptide longevity research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eMOTS-c is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use in any laboratory protocol. A common laboratory approach for the 10mg vial is reconstitution in 2ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e to yield a 5mg\/ml working stock, or in 1ml for a 10mg\/ml stock. For the 40mg vial, 4ml yields a 10mg\/ml stock, or 2ml yields a 20mg\/ml stock — researchers working with the larger vial typically aliquot reconstituted material to limit freeze-thaw cycles. The bacteriostatic water should be drawn into a sterile syringe and injected slowly down the inside wall of the lyophilised vial, allowing the peptide cake to dissolve passively rather than through agitation. Reconstituted MOTS-c should be aliquoted, refrigerated at 2–8°C and protected from light, with research stocks typically used within 30 days. For dilution maths across alternative volumes, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e. For long-term storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eIn published research and laboratory protocols, MOTS-c is often examined alongside other mitochondrial, longevity and metabolic research compounds:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ss-31-10mg\"\u003eSS-31\u003c\/a\u003e — mitochondrial-targeted peptide commonly co-investigated with MOTS-c in oxidative phosphorylation and cardiolipin protection research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/nad-1000mg\"\u003eNAD+\u003c\/a\u003e — co-investigated in mitochondrial redox and longevity research; NAD+ supports the sirtuin and electron-transport-chain pathways studied alongside MOTS-c.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glutathione-1500mg\"\u003eGlutathione\u003c\/a\u003e — examined alongside MOTS-c in research on mitochondrial redox status and antioxidant defence.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/epithalong-10mg\"\u003eEpithalon\u003c\/a\u003e — telomere and longevity research peptide commonly grouped with MOTS-c in anti-ageing study designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/5-amino-1mq-10mg\"\u003e5-Amino-1MQ\u003c\/a\u003e — NNMT inhibitor examined alongside MOTS-c in research on cellular methylation balance and metabolic phenotypes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader context on combined research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs MOTS-c legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eMOTS-c is a naturally occurring mitochondrial-derived peptide and is not a scheduled substance under the Australian Poisons Standard, but it is not registered as a therapeutic good with the TGA. Optic Labs supplies MOTS-c strictly for laboratory, research and analytical use only, not as a therapeutic good. For a full overview of how the Therapeutic Goods Administration treats research peptides in Australia, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003epeptide legality and TGA compliance guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is MOTS-c?\u003c\/h3\u003e\n\u003cp\u003eMOTS-c is a 16-amino-acid peptide encoded within the 12S rRNA region of mitochondrial DNA, identified in 2015 as one of the first mitochondrial-derived peptides. In published research it is studied as a regulator of cellular energy balance, glucose homeostasis and mitochondrial-nuclear retrograde signalling. For more detail, see our \u003ca href=\"\/blogs\/news\/mots-c-mitochondrial-peptide-longevity-research\"\u003eMOTS-c mitochondrial peptide research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat does MOTS-c do in published research?\u003c\/h3\u003e\n\u003cp\u003eIn published research, MOTS-c is studied for its effects on AMPK activation, insulin sensitivity, glucose homeostasis, mitochondrial-to-nuclear retrograde signalling, and as a candidate exercise mimetic in rodent models. It is also investigated as a circulating biomarker of mitochondrial function in ageing research. These observations are research findings only and do not constitute therapeutic claims.\u003c\/p\u003e\n\n\u003ch3\u003eHow is MOTS-c different from other peptides?\u003c\/h3\u003e\n\u003cp\u003eMost research peptides are encoded by the nuclear genome. MOTS-c is unusual in that it is encoded within mitochondrial DNA itself, in a small open reading frame inside the 12S rRNA gene. This makes MOTS-c part of a small but growing class of mitochondrial-derived peptides (MDPs), which also includes humanin and the SHLP family. The mitochondrial origin is what makes MOTS-c a distinctive research tool for studying mitochondrial-nuclear cross-talk.\u003c\/p\u003e\n\n\u003ch3\u003eHow is MOTS-c supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies MOTS-c as a lyophilised powder in glass research vials at 10mg and 40mg fill sizes. Each vial is sealed with a tamper-evident closure. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a 10mg or 40mg MOTS-c vial?\u003c\/h3\u003e\n\u003cp\u003eFor a 10mg vial, 2ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a 5mg\/ml working stock; 1ml yields a 10mg\/ml stock. For a 40mg vial, 4ml yields a 10mg\/ml stock and 2ml yields a 20mg\/ml stock. Choose a volume based on the concentrations required by the research protocol. For a worked example with unit conversions, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted MOTS-c be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted MOTS-c should be stored at 2–8°C, protected from light, and used within approximately 30 days. For longer-term storage, aliquoting and freezing at −20°C or below is preferred to limit freeze-thaw degradation. Full handling protocols are covered in our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"10mg","offer_id":53360884351160,"sku":null,"price":61.99,"currency_code":"AUD","in_stock":true},{"title":"40mg","offer_id":53360884383928,"sku":null,"price":156.99,"currency_code":"AUD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/motsc10.png?v=1776426196"},{"product_id":"melanotan-2-10mg","title":"Melanotan 2 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity Melanotan-2 (10mg) in Australia. Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout Melanotan-2\u003c\/h2\u003e\n\u003cp\u003eMelanotan-2 (MT-2) is a synthetic cyclic heptapeptide analogue of α-melanocyte-stimulating hormone (α-MSH), originally developed at the University of Arizona in the late 1980s as a research tool for studying the melanocortin receptor system.\u003c\/p\u003e\n\n\u003cp\u003eThe cyclic lactam bridge between Asp and Lys, together with the substitutions of Nle for Met and D-Phe for Phe, gives MT-2 substantially greater receptor-binding affinity, metabolic stability and functional duration than native α-MSH.\u003c\/p\u003e\n\n\u003cp\u003eIn published research, MT-2 is studied as a non-selective agonist of the melanocortin receptor family — primarily MC1R, MC3R and MC4R — and is one of the most extensively characterised research-grade melanocortin probes in the published literature.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies Melanotan-2 as a lyophilised powder in 10mg research vials, third-party HPLC tested to \u0026gt;99% purity. The product is distributed Australian-domestic from Sydney, NSW, for in vitro and laboratory research applications. Melanotan-2 is supplied strictly for laboratory research, development or analytical use and is not intended for human consumption, cosmetic use or any therapeutic application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Melanotan-2 (MT-2)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 121062-08-6\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e50\u003c\/sub\u003eH\u003csub\u003e69\u003c\/sub\u003eN\u003csub\u003e15\u003c\/sub\u003eO\u003csub\u003e9\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~1024.18 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH\u003csub\u003e2\u003c\/sub\u003e (cyclic heptapeptide)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable size:\u003c\/strong\u003e 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eMelanotan-2 was developed by Victor Hruby and colleagues at the University of Arizona as a stabilised, broad-spectrum analogue of α-MSH for use in melanocortin receptor research. The lactam-cyclised structure both restricts the peptide to its bioactive turn conformation and protects it from peptidase degradation, giving MT-2 a much longer functional half-life than the linear native hormone.\u003c\/p\u003e\n\n\u003cp\u003eThe same research programme later generated more selective analogues, including the MC4R-preferring compound bremelanotide (PT-141). MT-2 itself remains a standard pan-melanocortin agonist in research settings.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMelanocortin receptor pharmacology:\u003c\/strong\u003e in receptor-binding and cAMP accumulation assays, MT-2 acts as a non-selective agonist of MC1R, MC3R, MC4R and MC5R, with research interest in characterising downstream signalling profiles at each subtype.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMelanogenesis research:\u003c\/strong\u003e in melanocyte and melanoma cell-culture studies, MT-2 has been investigated for its effects on tyrosinase activity, MITF expression and the eumelanin\/pheomelanin synthesis ratio through MC1R activation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypothalamic energy balance:\u003c\/strong\u003e in rodent hypothalamic research, MT-2 has been examined as a tool for probing MC4R-mediated effects on food intake, body weight and adiposity in animal models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSexual function research:\u003c\/strong\u003e in published preclinical and clinical research, melanocortin receptor activation by MT-2 and the related selective analogue bremelanotide has been investigated in the context of central pathways involved in sexual behaviour.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiovascular and autonomic effects:\u003c\/strong\u003e in animal-model research, melanocortin receptor activation has been studied for effects on blood pressure, heart rate and central autonomic outflow.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInflammation and immune research:\u003c\/strong\u003e in cell-culture studies, melanocortin agonists have been examined for anti-inflammatory effects mediated through MC1R and MC3R on macrophages and other immune cells.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePhotoprotection research:\u003c\/strong\u003e in cell and animal models, MC1R activation has been studied for its effects on UV-induced DNA damage repair and oxidative stress responses in melanocytes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a plain-language overview of peptides, see our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e, and for laboratory injection protocols our \u003ca href=\"\/blogs\/news\/how-to-inject-peptides-subcutaneous-protocol\"\u003esubcutaneous injection protocol article\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eMelanotan-2 is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use in any laboratory protocol. A common laboratory approach for the 10mg vial is reconstitution in 2ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e to yield a 5mg\/ml working stock, or in 1ml for a 10mg\/ml stock.\u003c\/p\u003e\n\n\u003cp\u003eThe bacteriostatic water should be drawn into a sterile syringe and injected slowly down the inside wall of the lyophilised vial, allowing the peptide cake to dissolve passively rather than through agitation. Reconstituted MT-2 should be aliquoted, refrigerated at 2–8°C and protected from light, with research stocks typically used within 30 days.\u003c\/p\u003e\n\n\u003cp\u003eFor dilution maths across alternative volumes, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e. For long-term storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eIn published research and laboratory protocols, Melanotan-2 is examined alongside other melanocortin and pigmentation-pathway research compounds:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/pt-141-10mg\"\u003ePT-141 (bremelanotide)\u003c\/a\u003e — MC4R-preferring selective melanocortin agonist derived from the same research programme as MT-2.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ghk-cu-50mg-100mg\"\u003eGHK-Cu\u003c\/a\u003e — copper tripeptide examined alongside MT-2 in skin, fibroblast and pigmentation-related research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glutathione-1500mg\"\u003eGlutathione\u003c\/a\u003e — co-investigated in melanocyte research for its role in tyrosinase activity and pheomelanin\/eumelanin balance.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/aod-9604-5mg\"\u003eAOD-9604\u003c\/a\u003e — examined alongside MT-2 in metabolic and adiposity research where melanocortin pathway involvement is relevant.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/reta-10mg-15mg-20mg-30mg\"\u003eRetatrutide\u003c\/a\u003e — metabolic research peptide co-investigated in studies of central energy balance pathways that intersect with the melanocortin system.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader context on combined research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs Melanotan-2 legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eMelanotan-2 is not registered with the Therapeutic Goods Administration (TGA) for any therapeutic or cosmetic use in Australia, and the TGA has previously issued public safety advisories regarding the importation of injectable melanocortin products. Optic Labs supplies Melanotan-2 strictly as a research chemical for in vitro and preclinical laboratory research — not for human consumption, cosmetic application or any therapeutic use.\u003c\/p\u003e\n\n\u003cp\u003eFor a full overview of how the TGA treats research peptides in Australia, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003epeptide legality and TGA compliance guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is Melanotan-2?\u003c\/h3\u003e\n\u003cp\u003eMelanotan-2 is a synthetic cyclic heptapeptide analogue of α-melanocyte-stimulating hormone (α-MSH). In published research it acts as a non-selective agonist at the melanocortin receptor family (MC1R, MC3R, MC4R and MC5R) and is used as a research tool for probing melanocortin pharmacology. For a plain-language overview of peptides, see our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat does Melanotan-2 do in published research?\u003c\/h3\u003e\n\u003cp\u003eIn published research, Melanotan-2 is studied for its effects on melanocortin receptor signalling, melanocyte tyrosinase activity and the eumelanin\/pheomelanin synthesis ratio (via MC1R), hypothalamic regulation of food intake and energy balance (via MC4R), central pathways relevant to sexual behaviour, and macrophage anti-inflammatory signalling (via MC1R\/MC3R). These observations are research findings only and do not constitute therapeutic, cosmetic or pigmentation-related claims.\u003c\/p\u003e\n\n\u003ch3\u003eHow does Melanotan-2 compare with PT-141 in research?\u003c\/h3\u003e\n\u003cp\u003eMelanotan-2 and \u003ca href=\"\/products\/pt-141-10mg\"\u003ePT-141 (bremelanotide)\u003c\/a\u003e were developed in the same research programme. MT-2 is a non-selective melanocortin agonist active at MC1R through MC5R, while PT-141 was engineered as a more MC4R-preferring analogue, removing some of the MC1R-mediated pigmentation activity. In research settings the two are used to probe distinct subsets of the melanocortin system.\u003c\/p\u003e\n\n\u003ch3\u003eHow is Melanotan-2 supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies Melanotan-2 as a lyophilised powder in 10mg glass research vials. Each vial is sealed with a tamper-evident closure. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a 10mg Melanotan-2 vial?\u003c\/h3\u003e\n\u003cp\u003eFor a 10mg vial, 2ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a 5mg\/ml working stock; 1ml yields a 10mg\/ml stock; 5ml yields a 2mg\/ml stock. Choose a volume based on the concentrations required by the research protocol. For a worked example with unit conversions, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted Melanotan-2 be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted Melanotan-2 should be stored at 2–8°C, protected from light, and used within approximately 30 days. For longer-term storage, aliquoting and freezing at −20°C or below is preferred to limit freeze-thaw degradation. Full handling protocols are covered in our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease.\u003c\/p\u003e\n\n\u003cp\u003eOptic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884416696,"sku":null,"price":61.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/mt2-10.png?v=1776426194"},{"product_id":"kpv-10mg","title":"KPV 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity KPV in Australia (10mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout KPV\u003c\/h2\u003e\n\u003cp\u003eKPV is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH), composed of the sequence lysine–proline–valine. The peptide retains many of the anti-inflammatory and immunomodulatory characteristics attributed to the parent α-MSH molecule, but in a much smaller, more chemically tractable form. KPV has become a focal point for laboratory investigation of melanocortin-pathway-independent anti-inflammatory mechanisms, particularly in epithelial and mucosal tissue models.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies KPV as a lyophilised research-grade powder for laboratories investigating gut-barrier integrity, dermal inflammation, mast-cell behaviour, and innate-immune signalling. Each vial is third-party HPLC verified at \u0026gt;99% purity. KPV peptide is supplied for laboratory research use only and is not intended for human consumption, cosmetic application, or any therapeutic purpose.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e KPV (Lysine–Proline–Valine)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 67727-97-3\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e16\u003c\/sub\u003eH\u003csub\u003e30\u003c\/sub\u003eN\u003csub\u003e4\u003c\/sub\u003eO\u003csub\u003e4\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~342.4 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e Lys-Pro-Val (KPV)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eKPV was first characterised in the 1980s and 1990s as a minimal active fragment of α-MSH (α-melanocyte-stimulating hormone), retaining anti-inflammatory activity in the apparent absence of melanocortin-receptor binding. This made KPV an unusual research tool — a small peptide capable of modulating inflammation through receptor-independent intracellular pathways. Since then, the peptide has appeared across multiple lines of preclinical inflammation research.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNF-κB pathway modulation\u003c\/strong\u003e — in cell-culture studies, KPV has been reported to interfere with NF-κB nuclear translocation, an upstream regulator of pro-inflammatory cytokine transcription.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eColitis and gut-barrier models\u003c\/strong\u003e — published animal studies in DSS- and TNBS-induced colitis have explored KPV as a candidate for restoring intestinal epithelial integrity and reducing mucosal inflammation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMast-cell activity\u003c\/strong\u003e — preclinical work has examined the peptide's effect on mast-cell degranulation and histamine-mediated inflammatory cascades.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDermal and atopic models\u003c\/strong\u003e — KPV has been investigated topically in animal models of contact dermatitis and atopic-style skin inflammation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePepT1 transporter uptake\u003c\/strong\u003e — research has characterised KPV as a substrate for the intestinal PepT1 di\/tripeptide transporter, supporting its use in oral-delivery research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCytokine profiling\u003c\/strong\u003e — laboratory investigations have profiled changes in TNF-α, IL-6, and IL-1β following KPV exposure in inflammatory cell models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnti-microbial activity\u003c\/strong\u003e — fragment-based research has reported activity against certain dermatophyte and yeast species in vitro.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary, see our \u003ca href=\"\/blogs\/news\/kpv-peptide-australia-anti-inflammatory-research\"\u003eKPV anti-inflammatory research guide\u003c\/a\u003e and our broader \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eKPV is supplied as a lyophilised powder and is reconstituted prior to use with sterile \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e. A common laboratory approach is to add 2 mL of bac water to a 10mg vial, yielding a 5 mg\/mL working concentration; at this concentration, 0.1 mL drawn into an insulin syringe corresponds to 500 µg of peptide. Reconstituted KPV should be stored at 2–8°C, protected from light, and used within 30 days. For step-by-step dilution mathematics, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eIn published stack-design literature, KPV is frequently grouped with other peptides under investigation for tissue-repair, gut-barrier, and skin-inflammation research. Researchers commonly cross-reference:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/bpc-157\"\u003eBPC-157\u003c\/a\u003e — gastric-derived pentadecapeptide investigated for gut-barrier and angiogenesis research, often paired with KPV in mucosal-integrity work.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tb-500\"\u003eTB-500\u003c\/a\u003e — thymosin β4 fragment used in tissue-repair research, complementing KPV in injury and inflammation models.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ghk-cu-50mg-100mg\"\u003eGHK-Cu\u003c\/a\u003e — copper-binding tripeptide investigated for dermal remodelling, often referenced alongside KPV in skin-inflammation research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/klow80-bpc-157-10mg-ghk-cu-50mg-tb-500-10mg-kpv-10mg\"\u003eKLOW80 stack\u003c\/a\u003e — pre-formulated combination of BPC-157, GHK-Cu, TB-500 and KPV used in stack-design research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glutathione-1500mg\"\u003eGlutathione\u003c\/a\u003e — tripeptide antioxidant cross-referenced with KPV in redox and inflammation research designs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor more on multi-peptide research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs KPV legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eKPV is supplied by Optic Labs strictly for laboratory research, development and analytical use. It is not approved by the Therapeutic Goods Administration for human therapeutic use and is not a registered medicine. For a detailed overview of Australian peptide research regulation, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is KPV?\u003c\/h3\u003e\n\u003cp\u003eKPV is a synthetic tripeptide consisting of the amino acids lysine, proline and valine — the C-terminal three residues of α-melanocyte-stimulating hormone (α-MSH). It is studied in laboratory research for its anti-inflammatory and immunomodulatory characteristics. See our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e for broader context.\u003c\/p\u003e\n\n\u003ch3\u003eWhat does KPV research focus on?\u003c\/h3\u003e\n\u003cp\u003ePublished research has examined KPV in cell-culture and animal models of intestinal inflammation, dermatitis, mast-cell activation and NF-κB-mediated cytokine signalling. The peptide is studied as a small, receptor-independent anti-inflammatory tool rather than a melanocortin-pathway agonist.\u003c\/p\u003e\n\n\u003ch3\u003eHow is KPV supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies KPV as a lyophilised powder in glass research vials, available in 10mg. Each vial is sealed and shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a KPV 10mg vial?\u003c\/h3\u003e\n\u003cp\u003eA common laboratory dilution is 2 mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e per 10mg vial, giving a 5 mg\/mL solution. The exact volume depends on your research protocol — see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e for dilution mathematics.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted KPV be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted KPV should be kept at 2–8°C, protected from light, and used within 30 days. Long-term storage of unreconstituted lyophilised powder should be at −20°C or colder. See our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage complete research guide\u003c\/a\u003e for handling detail.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884515000,"sku":null,"price":61.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/kpv10.png?v=1776426193"},{"product_id":"klow80-bpc-157-10mg-ghk-cu-50mg-tb-500-10mg-kpv-10mg","title":"KLOW80 (BPC-157 10mg + GHK-CU 50mg + TB-500 10mg + KPV 10mg)","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity KLOW80 stack in Australia (BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg + KPV 10mg, 80mg total). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout the KLOW80 stack\u003c\/h2\u003e\n\u003cp\u003eKLOW80 is a four-compound research stack co-lyophilised in a single vial: 10mg BPC-157 (a pentadecapeptide derived from gastric juice protein BPC), 50mg GHK-Cu (a copper-binding tripeptide), 10mg TB-500 (a 17-amino-acid fragment of thymosin β-4), and 10mg KPV (an α-MSH-derived tripeptide, Lys-Pro-Val). KLOW80 extends the GLOW70 stack with KPV's anti-inflammatory and gut-barrier research profile, giving researchers a single working unit that spans angiogenic, copper-dependent collagen-synthesis, actin-remodelling and α-MSH-pathway tools. It is a frequent choice in animal-model and cell-culture research where investigators want broad coverage of repair and inflammatory pathways in parallel.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies KLOW80 in Australia as a co-lyophilised powder, 80mg total, third-party HPLC verified at \u0026gt;99% purity for each constituent peptide. The stack is supplied strictly for laboratory research use only and is not intended for human consumption, clinical, cosmetic, diagnostic or veterinary application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e BPC-157 (10mg) + GHK-Cu (50mg) + TB-500 (10mg) + KPV (10mg) co-lyophilised stack\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157:\u003c\/strong\u003e CAS 137525-51-0, ~1419.5 g\/mol, pentadecapeptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu:\u003c\/strong\u003e CAS 49557-75-7 (peptide) \/ 89030-95-5 (copper-bound), ~340.4 g\/mol (free peptide), Gly-His-Lys with Cu\u003csup\u003e2+\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500:\u003c\/strong\u003e CAS 77591-33-4, 17-amino-acid fragment of thymosin β-4\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eKPV:\u003c\/strong\u003e CAS 67727-97-3, ~342.4 g\/mol, Lys-Pro-Val tripeptide derived from α-MSH\u003csub\u003e(11–13)\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder (co-formulated)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC for each peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable size:\u003c\/strong\u003e 80mg total per vial (10mg BPC-157 + 50mg GHK-Cu + 10mg TB-500 + 10mg KPV)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eThe four peptides in KLOW80 cover overlapping but distinct repair and inflammatory pathways. BPC-157 is characterised in published research for angiogenic, nitric-oxide and growth-factor signalling; GHK-Cu for copper-dependent collagen synthesis and gene-expression modulation; TB-500 for actin sequestration and cell migration; KPV for α-MSH-pathway anti-inflammatory effects and gut-barrier research. Combining them allows investigators to probe parallel pathway engagement in connective-tissue, dermal, gastrointestinal and inflammation models within a single working unit.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eBPC-157: tendon, ligament and gastrointestinal injury models examining VEGF\/eNOS signalling and fibroblast outgrowth.\u003c\/li\u003e\n\u003cli\u003eGHK-Cu: collagen and elastin synthesis research in dermal fibroblasts and ex-vivo skin models.\u003c\/li\u003e\n\u003cli\u003eGHK-Cu: gene-expression studies modulating antioxidant, anti-inflammatory and tissue-remodelling pathways.\u003c\/li\u003e\n\u003cli\u003eTB-500: G-actin sequestration and actin-cytoskeleton remodelling research relevant to cell migration.\u003c\/li\u003e\n\u003cli\u003eTB-500: cardiac, dermal, corneal and hair-follicle research examining endothelial and keratinocyte migration.\u003c\/li\u003e\n\u003cli\u003eKPV: α-MSH-derived tripeptide research on NF-κB modulation and pro-inflammatory cytokine attenuation in cell-culture and rodent colitis models.\u003c\/li\u003e\n\u003cli\u003eCombined-peptide protocols in models combining inflammatory and repair endpoints, where multi-pathway coverage is the design objective.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor deeper background, see our \u003ca href=\"\/blogs\/news\/bpc-157-complete-research-guide-2025\"\u003eBPC-157 complete research guide\u003c\/a\u003e, our \u003ca href=\"\/blogs\/news\/ghk-cu-australia-copper-peptide-guide\"\u003eGHK-Cu copper peptide guide\u003c\/a\u003e, our \u003ca href=\"\/blogs\/news\/tb-500-australia-thymosin-injury-research-guide\"\u003eTB-500 research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/kpv-peptide-australia-anti-inflammatory-research\"\u003eKPV anti-inflammatory research guide\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eKLOW80 is co-lyophilised — all four peptides dissolve together when the vial is reconstituted. Use sterile \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e. Adding 4mL of bacteriostatic water to an 80mg vial yields 20mg\/mL total peptide, which corresponds to 2.5mg\/mL BPC-157, 12.5mg\/mL GHK-Cu, 2.5mg\/mL TB-500 and 2.5mg\/mL KPV. A 5mL reconstitution gives 16mg\/mL total (2mg\/mL BPC-157, 10mg\/mL GHK-Cu, 2mg\/mL TB-500, 2mg\/mL KPV). Add diluent slowly down the side of the vial — do not inject directly onto the lyophilised cake — and allow the powder to dissolve without vigorous shaking. Reconstituted KLOW80 should be stored at 2–8°C, protected from light, and used within 30 days. For dilution maths for any working volume, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution calculator guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eResearchers using KLOW80 commonly hold its constituent peptides separately for protocols requiring different ratios or single-compound arms:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/bpc-157\"\u003eBPC-157\u003c\/a\u003e — single-compound vial for protocols at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ghk-cu-50mg-100mg\"\u003eGHK-Cu\u003c\/a\u003e — single-compound copper-peptide vial.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tb-500\"\u003eTB-500\u003c\/a\u003e — single-compound thymosin β-4 fragment vial.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/kpv-10mg\"\u003eKPV\u003c\/a\u003e — single-compound α-MSH-derived tripeptide for anti-inflammatory and gut-barrier research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glow70-bpc-157-10mg-ghk-cu-50mg-tb-500-10mg\"\u003eGLOW70 stack\u003c\/a\u003e — three-compound version of KLOW80 without the KPV arm.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader stack-design context, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs KLOW80 legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eNone of the constituent peptides — BPC-157, GHK-Cu, TB-500 or KPV — is an approved therapeutic good in Australia, and none is registered with the Therapeutic Goods Administration (TGA). Optic Labs supplies KLOW80 strictly for laboratory research, development and analytical use — not for human consumption, clinical or cosmetic application. For a detailed overview of how research peptides sit within the Australian regulatory framework, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is KLOW80?\u003c\/h3\u003e\n\u003cp\u003eKLOW80 is a co-lyophilised four-compound research stack containing 10mg BPC-157, 50mg GHK-Cu, 10mg TB-500 and 10mg KPV in a single vial. The four peptides are co-studied in repair, dermal, gastrointestinal and inflammation research. For background on each, see our \u003ca href=\"\/blogs\/news\/bpc-157-complete-research-guide-2025\"\u003eBPC-157\u003c\/a\u003e, \u003ca href=\"\/blogs\/news\/ghk-cu-australia-copper-peptide-guide\"\u003eGHK-Cu\u003c\/a\u003e, \u003ca href=\"\/blogs\/news\/tb-500-australia-thymosin-injury-research-guide\"\u003eTB-500\u003c\/a\u003e and \u003ca href=\"\/blogs\/news\/kpv-peptide-australia-anti-inflammatory-research\"\u003eKPV\u003c\/a\u003e guides.\u003c\/p\u003e\n\n\u003ch3\u003eHow does KLOW80 differ from GLOW70?\u003c\/h3\u003e\n\u003cp\u003eKLOW80 is essentially the GLOW70 stack with an additional 10mg of KPV added to the same vial. Researchers who want anti-inflammatory and gut-barrier pathway coverage alongside the angiogenic, copper-dependent collagen-synthesis and actin-remodelling tools of GLOW70 typically reach for KLOW80; researchers running designs without an inflammation arm typically use \u003ca href=\"\/products\/glow70-bpc-157-10mg-ghk-cu-50mg-tb-500-10mg\"\u003eGLOW70\u003c\/a\u003e instead.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a KLOW80 vial?\u003c\/h3\u003e\n\u003cp\u003eFor an 80mg vial, 4mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields 20mg\/mL total peptide (2.5mg\/mL BPC-157, 12.5mg\/mL GHK-Cu, 2.5mg\/mL TB-500, 2.5mg\/mL KPV). 5mL gives 16mg\/mL total. See our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e for worked examples at other volumes.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted KLOW80 be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted KLOW80 should be stored at 2–8°C, protected from light, and used within 30 days. Lyophilised vials are stable at 2–8°C until reconstitution. For full handling guidance, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884547768,"sku":null,"price":180.99,"currency_code":"AUD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/klow_2e301683-3a56-4d55-8137-0d8348284b8e.png?v=1776428395"},{"product_id":"glutathione-1500mg","title":"Glutathione 1500mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity glutathione (1500mg) in Australia. Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout glutathione\u003c\/h2\u003e\n\u003cp\u003eGlutathione (GSH) is an endogenous tripeptide composed of glutamate, cysteine and glycine, present in virtually every mammalian cell. It is the principal low-molecular-weight thiol antioxidant in eukaryotic cells and is central to redox homeostasis, phase II detoxification and the regulation of intracellular cysteine pools.\u003c\/p\u003e\n\n\u003cp\u003eIn published research, glutathione is most often studied in the context of oxidative stress, hepatic detoxification pathways, immune cell function and mitochondrial redox status.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies glutathione as a lyophilised powder in 1500mg research vials, third-party HPLC tested to \u0026gt;99% purity. The product is distributed Australian-domestic from Sydney, NSW, for in vitro and laboratory research applications. Glutathione is supplied strictly for laboratory research, development or analytical use and is not intended for human consumption.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e L-Glutathione (reduced; γ-L-glutamyl-L-cysteinyl-glycine)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 70-18-8\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e10\u003c\/sub\u003eH\u003csub\u003e17\u003c\/sub\u003eN\u003csub\u003e3\u003c\/sub\u003eO\u003csub\u003e6\u003c\/sub\u003eS\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~307.32 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e γ-Glu-Cys-Gly (tripeptide)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable size:\u003c\/strong\u003e 1500mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eGlutathione was first isolated from yeast in 1888 and structurally characterised in the 1920s by Frederick Gowland Hopkins, who established its tripeptide identity. Since then it has become one of the most extensively studied small molecules in biochemistry, with the GSH\/GSSG (reduced\/oxidised) ratio used as a standard biomarker of intracellular redox state in cell-culture and animal model research.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAntioxidant defence:\u003c\/strong\u003e in cell-culture studies, glutathione donates electrons via glutathione peroxidase (GPx) to neutralise hydrogen peroxide and lipid peroxides, with oxidised GSSG recycled by glutathione reductase using NADPH.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePhase II detoxification:\u003c\/strong\u003e in hepatocyte and liver-tissue research, glutathione conjugation via glutathione S-transferases (GSTs) is a primary mechanism for clearing electrophilic xenobiotics, including paracetamol-derived NAPQI in animal toxicology models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMitochondrial redox:\u003c\/strong\u003e mitochondrial glutathione (mtGSH) is studied in models of oxidative phosphorylation dysfunction, complex I inhibition and age-related mitochondrial decline.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmune cell function:\u003c\/strong\u003e in T-cell and macrophage research, intracellular GSH levels modulate cytokine profiles, NF-κB signalling and proliferation under oxidative challenge.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProtein S-glutathionylation:\u003c\/strong\u003e reversible binding of GSH to protein cysteine residues is a regulatory post-translational modification studied in cardiac, neuronal and skeletal muscle models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlutathione depletion models:\u003c\/strong\u003e buthionine sulfoximine (BSO) is used in rodent and cell research to inhibit γ-glutamylcysteine synthetase and study GSH depletion phenotypes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSkin and melanocyte cell research:\u003c\/strong\u003e in cell-culture studies, glutathione has been examined for its role in tyrosinase activity and pheomelanin\/eumelanin balance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary, see our \u003ca href=\"\/blogs\/news\/glutathione-australia-antioxidant-research-guide\"\u003eglutathione antioxidant research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eUnlike most short-chain research peptides, glutathione is highly water-soluble and can be reconstituted at relatively high concentrations. A common laboratory approach for the 1500mg vial is reconstitution in 5ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e to yield a 300mg\/ml working stock, or in 10ml for a 150mg\/ml stock.\u003c\/p\u003e\n\n\u003cp\u003eGlutathione is sensitive to oxidation in solution, particularly at neutral and alkaline pH, so reconstituted solutions should be aliquoted, kept refrigerated at 2–8°C and protected from light. For dilution maths across alternative volumes, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e. For long-term storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eIn published research and laboratory protocols, glutathione is often examined alongside other antioxidant, longevity and mitochondrial-function compounds:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/nad-1000mg\"\u003eNAD+\u003c\/a\u003e — co-investigated in mitochondrial redox and longevity research; NAD+ supports the NADPH pool that regenerates reduced glutathione.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ss-31-10mg\"\u003eSS-31\u003c\/a\u003e — mitochondrial-targeted peptide commonly studied alongside GSH in oxidative phosphorylation and cardiolipin protection models.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/mots-c-10mg-40mg\"\u003eMOTS-c\u003c\/a\u003e — mitochondrial-derived peptide investigated for metabolic and redox effects in parallel with glutathione status.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ghk-cu-50mg-100mg\"\u003eGHK-Cu\u003c\/a\u003e — copper peptide studied alongside glutathione in skin, fibroblast and antioxidant gene-expression research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/epithalong-10mg\"\u003eEpithalon\u003c\/a\u003e — telomere and longevity research peptide frequently grouped with GSH in anti-ageing study designs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader context on combined research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs glutathione legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eGlutathione is a naturally occurring tripeptide and is not a scheduled substance under the Australian Poisons Standard. However, products supplied for laboratory research are regulated differently from therapeutic goods. Optic Labs supplies glutathione strictly for laboratory, research and analytical use only, not as a therapeutic good.\u003c\/p\u003e\n\n\u003cp\u003eFor a full overview of how the Therapeutic Goods Administration treats research peptides in Australia, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003epeptide legality and TGA compliance guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is glutathione?\u003c\/h3\u003e\n\u003cp\u003eGlutathione is a tripeptide of glutamate, cysteine and glycine, found at high intracellular concentrations in virtually all mammalian cells. It is the body's major non-enzymatic thiol antioxidant and a central substrate in phase II liver detoxification. For a plain-language overview of peptides and how they differ from small-molecule drugs, see our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat does glutathione do in published research?\u003c\/h3\u003e\n\u003cp\u003eIn published in vitro and animal research, glutathione is studied as an electron donor for glutathione peroxidase (neutralising peroxides), as a conjugation partner in xenobiotic clearance via glutathione S-transferases, as a regulator of protein function via reversible S-glutathionylation, and as a marker of redox state through the GSH\/GSSG ratio.\u003c\/p\u003e\n\n\u003cp\u003eResearchers also examine its role in mitochondrial redox balance and immune cell signalling. These observations are research findings only and do not constitute therapeutic claims.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is typically considered when working with glutathione in solution?\u003c\/h3\u003e\n\u003cp\u003eResearchers commonly account for glutathione's susceptibility to oxidation in aqueous solution, particularly at neutral or alkaline pH and in the presence of trace metals. Working stocks are usually prepared fresh, aliquoted to minimise freeze-thaw cycles, kept cold and shielded from light. In cell-culture work, GSH is often paired with chelators or prepared in degassed buffer to limit auto-oxidation prior to assay.\u003c\/p\u003e\n\n\u003ch3\u003eHow is glutathione supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies glutathione as a lyophilised powder in glass research vials at a 1500mg fill. Each vial is sealed with a tamper-evident closure. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a 1500mg glutathione vial?\u003c\/h3\u003e\n\u003cp\u003eFor a 1500mg vial, 5ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a 300mg\/ml working stock; 10ml yields a 150mg\/ml stock; 15ml yields a 100mg\/ml stock. Choose a volume based on the concentrations required by the research protocol. For a step-by-step worked example with unit conversions, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted glutathione be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted glutathione should be stored at 2–8°C, protected from light, and used within approximately 30 days. For longer-term storage, aliquoting and freezing at −20°C or below is preferred to limit oxidation and freeze-thaw degradation. Full handling protocols are covered in our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease.\u003c\/p\u003e\n\n\u003cp\u003eOptic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884678840,"sku":null,"price":94.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/glutathione_55dfce13-ce84-4a3a-824e-b3aab73ebb2a.png?v=1776428196"},{"product_id":"glow70-bpc-157-10mg-ghk-cu-50mg-tb-500-10mg","title":"GLOW70 (BPC-157 10mg + GHK-CU 50mg + TB-500 10mg)","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity GLOW70 stack in Australia (BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg, 70mg total). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout the GLOW70 stack\u003c\/h2\u003e\n\u003cp\u003eGLOW70 is a three-compound research stack co-lyophilised in a single vial: 10mg BPC-157 (a pentadecapeptide derived from gastric juice protein BPC), 50mg GHK-Cu (a copper-binding tripeptide), and 10mg TB-500 (a 17-amino-acid fragment of thymosin β-4). The combination assembles three of the most extensively studied peptides in regenerative, dermal and connective-tissue research into a single working unit, sized to the typical mass ratios used in published animal-model and cell-culture protocols. GLOW70 is a popular tool when researchers want to examine angiogenic, copper-dependent collagen-synthesis and actin-remodelling pathways in parallel rather than across separate vials.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies GLOW70 in Australia as a co-lyophilised powder, 70mg total, third-party HPLC verified at \u0026gt;99% purity for each constituent peptide. The stack is supplied strictly for laboratory research use only and is not intended for human consumption, clinical, cosmetic, diagnostic or veterinary application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e BPC-157 (10mg) + GHK-Cu (50mg) + TB-500 (10mg) co-lyophilised stack\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157:\u003c\/strong\u003e CAS 137525-51-0, ~1419.5 g\/mol, pentadecapeptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGHK-Cu:\u003c\/strong\u003e CAS 49557-75-7 (peptide) \/ 89030-95-5 (copper-bound), ~340.4 g\/mol (free peptide), Gly-His-Lys with Cu\u003csup\u003e2+\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500:\u003c\/strong\u003e CAS 77591-33-4, 17-amino-acid fragment of thymosin β-4\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder (co-formulated)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC for each peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable size:\u003c\/strong\u003e 70mg total per vial (10mg BPC-157 + 50mg GHK-Cu + 10mg TB-500)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eThe three peptides in GLOW70 are studied across overlapping but distinct repair and regenerative pathways. BPC-157 is characterised in the literature for angiogenic, nitric-oxide and growth-factor signalling; GHK-Cu for copper-dependent collagen synthesis, antioxidant gene expression and dermal remodelling; TB-500 for actin sequestration, cell migration and microvascular development. Combining them is a common research design when investigators want to probe parallel pathway engagement in connective-tissue, dermal and wound-healing models.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eBPC-157: tendon, ligament and gastrointestinal injury models examining fibroblast outgrowth and VEGF\/eNOS signalling.\u003c\/li\u003e\n\u003cli\u003eGHK-Cu: copper-binding tripeptide research on collagen and elastin synthesis in dermal fibroblasts and ex-vivo skin models.\u003c\/li\u003e\n\u003cli\u003eGHK-Cu: gene-expression studies in cultured cells reporting modulation of antioxidant, anti-inflammatory and tissue-remodelling pathways.\u003c\/li\u003e\n\u003cli\u003eTB-500: G-actin sequestration and actin-cytoskeleton remodelling research relevant to cell migration.\u003c\/li\u003e\n\u003cli\u003eTB-500: cardiac, dermal, corneal and hair-follicle research examining endothelial and keratinocyte migration.\u003c\/li\u003e\n\u003cli\u003eCombined-peptide protocols in rodent wound and musculoskeletal-injury models examining repair time-course versus single-peptide arms.\u003c\/li\u003e\n\u003cli\u003eSkin and dermal-research designs examining whether BPC-157 + GHK-Cu + TB-500 produces additive effects on fibroblast activity and microvasculature.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor deeper background, see our \u003ca href=\"\/blogs\/news\/bpc-157-complete-research-guide-2025\"\u003eBPC-157 complete research guide\u003c\/a\u003e, our \u003ca href=\"\/blogs\/news\/ghk-cu-australia-copper-peptide-guide\"\u003eGHK-Cu copper peptide guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/tb-500-australia-thymosin-injury-research-guide\"\u003eTB-500 research guide\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eGLOW70 is co-lyophilised — all three peptides dissolve together when the vial is reconstituted. Use sterile \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e. Adding 3mL of bacteriostatic water to a 70mg vial yields approximately 23.3mg\/mL total peptide, which corresponds to 3.33mg\/mL BPC-157, 16.67mg\/mL GHK-Cu and 3.33mg\/mL TB-500. A 5mL reconstitution gives 14mg\/mL total (2mg\/mL BPC-157, 10mg\/mL GHK-Cu, 2mg\/mL TB-500), which is often more convenient for protocols where smaller working volumes are dosed. Add diluent slowly down the side of the vial — do not inject directly onto the lyophilised cake — and allow the powder to dissolve without vigorous shaking. Reconstituted GLOW70 should be stored at 2–8°C, protected from light, and used within 30 days. For dilution maths for any working volume, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution calculator guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eResearchers using GLOW70 commonly hold its constituent peptides separately for protocols requiring different ratios, alongside related repair and anti-inflammatory tools:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/bpc-157\"\u003eBPC-157\u003c\/a\u003e — single-compound vial for protocols at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ghk-cu-50mg-100mg\"\u003eGHK-Cu\u003c\/a\u003e — single-compound copper-peptide vial for collagen and dermal-research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tb-500\"\u003eTB-500\u003c\/a\u003e — single-compound thymosin β-4 fragment vial.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/bpc-157-tb-500-10mg-20mg\"\u003eBPC-157 + TB-500 blend\u003c\/a\u003e — two-compound vial for repair-pathway research without the GHK-Cu arm.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/klow80-bpc-157-10mg-ghk-cu-50mg-tb-500-10mg-kpv-10mg\"\u003eKLOW80 stack\u003c\/a\u003e — four-compound stack adding KPV to the GLOW70 base for anti-inflammatory pathway coverage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader stack-design context, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs GLOW70 legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eNone of the constituent peptides — BPC-157, GHK-Cu or TB-500 — is an approved therapeutic good in Australia, and none is registered with the Therapeutic Goods Administration (TGA). Optic Labs supplies GLOW70 strictly for laboratory research, development and analytical use — not for human consumption, clinical or cosmetic application. For a detailed overview of how research peptides sit within the Australian regulatory framework, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is GLOW70?\u003c\/h3\u003e\n\u003cp\u003eGLOW70 is a co-lyophilised three-compound research stack containing 10mg BPC-157, 50mg GHK-Cu and 10mg TB-500 in a single vial. The three peptides are widely co-studied in regenerative, dermal and connective-tissue research. For background on each, see our \u003ca href=\"\/blogs\/news\/bpc-157-complete-research-guide-2025\"\u003eBPC-157\u003c\/a\u003e, \u003ca href=\"\/blogs\/news\/ghk-cu-australia-copper-peptide-guide\"\u003eGHK-Cu\u003c\/a\u003e and \u003ca href=\"\/blogs\/news\/tb-500-australia-thymosin-injury-research-guide\"\u003eTB-500\u003c\/a\u003e guides.\u003c\/p\u003e\n\n\u003ch3\u003eWhy use GLOW70 instead of three separate vials?\u003c\/h3\u003e\n\u003cp\u003eA co-lyophilised stack reduces handling steps and reconstitution events when a protocol consistently uses all three peptides together at this 1:5:1 mass ratio. For protocols that require unequal ratios, single-peptide arms or dose-escalation across one peptide, separate \u003ca href=\"\/products\/bpc-157\"\u003eBPC-157\u003c\/a\u003e, \u003ca href=\"\/products\/ghk-cu-50mg-100mg\"\u003eGHK-Cu\u003c\/a\u003e and \u003ca href=\"\/products\/tb-500\"\u003eTB-500\u003c\/a\u003e vials are the appropriate choice.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a GLOW70 vial?\u003c\/h3\u003e\n\u003cp\u003eFor a 70mg vial, 3mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields approximately 23.3mg\/mL total peptide (3.33mg\/mL BPC-157, 16.67mg\/mL GHK-Cu, 3.33mg\/mL TB-500). 5mL gives 14mg\/mL total. See our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e for worked examples at other volumes.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted GLOW70 be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted GLOW70 should be stored at 2–8°C, protected from light, and used within 30 days. Lyophilised vials are stable at 2–8°C until reconstitution. For full handling guidance, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884711608,"sku":null,"price":161.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/glow_270793dd-cf47-4165-b65d-be2e8a9d47e1.png?v=1776428153"},{"product_id":"epithalong-10mg","title":"Epithalong 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity Epithalon in Australia (10mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout Epithalon\u003c\/h2\u003e\n\u003cp\u003eEpithalon (also spelled epitalon, and sometimes referenced as \"Epithalong\") is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly. It was derived from epithalamin, a polypeptide preparation of the pineal gland investigated extensively in the late twentieth century in Russian gerontology research. Epithalon distils that activity into a four-residue peptide and has since become a widely cited research compound in laboratory studies of telomere biology, circadian regulation, and cellular ageing.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies Epithalon as a lyophilised research-grade peptide for laboratories investigating telomerase activity, pineal-axis signalling, and gene-expression changes associated with senescence. Each vial is third-party HPLC verified at \u0026gt;99% purity. Epithalon peptide is supplied for laboratory research use only and is not intended for human consumption, cosmetic application, or any therapeutic purpose.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Epithalon (Epitalon, Epithalong)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 307297-39-8\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e14\u003c\/sub\u003eH\u003csub\u003e22\u003c\/sub\u003eN\u003csub\u003e4\u003c\/sub\u003eO\u003csub\u003e9\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~390.35 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e Ala-Glu-Asp-Gly (AEDG)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eEpithalon was developed by Vladimir Khavinson and colleagues at the St Petersburg Institute of Bioregulation and Gerontology as a short synthetic analogue of the pineal extract epithalamin. Across several decades of laboratory and clinical-population research, it has been investigated for effects on the pineal–melatonin axis, telomere maintenance, and biomarkers of biological ageing. Modern published research continues to use Epithalon as a probe for short-peptide regulation of gene expression.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTelomerase activity\u003c\/strong\u003e — in cell-culture studies, Epithalon has been reported to upregulate telomerase reverse transcriptase (hTERT) expression and extend telomere length in somatic cell lines.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePineal–melatonin axis\u003c\/strong\u003e — animal-model research has examined Epithalon's effect on pineal function, melatonin rhythm, and circadian regulation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGene-expression modulation\u003c\/strong\u003e — laboratory work has explored AEDG's interaction with histones and gene-promoter regions, characterising it as an epigenetic short-peptide regulator.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLifespan studies in animal models\u003c\/strong\u003e — published rodent studies have explored Epithalon's effect on median and maximum lifespan, age-related mortality, and tumour incidence.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAntioxidant and oxidative-stress markers\u003c\/strong\u003e — research has tracked changes in lipid peroxidation, glutathione, and other oxidative-stress markers in Epithalon-exposed tissue models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRetinal and visual-system models\u003c\/strong\u003e — preclinical investigation has examined Epithalon in models of retinal degeneration and age-related ocular change.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmunological ageing\u003c\/strong\u003e — laboratory studies have profiled changes in T-cell subsets and immune-marker expression in ageing animal models exposed to Epithalon.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary, see our \u003ca href=\"\/blogs\/news\/epithalon-australia-telomere-anti-aging-guide\"\u003eEpithalon telomere and anti-ageing research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/nad-plus-australia-longevity-research-guide\"\u003eNAD+ longevity research guide\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eEpithalon is supplied as a lyophilised powder and is reconstituted prior to use with sterile \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e. A common laboratory approach is to add 2 mL of bac water to a 10mg vial, yielding a 5 mg\/mL working concentration; at this concentration, 0.1 mL drawn into an insulin syringe corresponds to 500 µg of peptide. Reconstituted Epithalon should be stored at 2–8°C, protected from light, and used within 30 days. For step-by-step dilution mathematics, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eIn published longevity and ageing research, Epithalon is frequently grouped with other peptides and compounds investigated for cellular-ageing, mitochondrial and antioxidant research:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/nad-1000mg\"\u003eNAD+\u003c\/a\u003e — coenzyme central to sirtuin and DNA-repair pathways often co-studied with Epithalon in ageing research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/mots-c-10mg-40mg\"\u003eMOTS-c\u003c\/a\u003e — mitochondrial-derived peptide cross-referenced with Epithalon in mitochondrial ageing research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glutathione-1500mg\"\u003eGlutathione\u003c\/a\u003e — endogenous tripeptide antioxidant studied alongside Epithalon in oxidative-stress and senescence models.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ghk-cu-50mg-100mg\"\u003eGHK-Cu\u003c\/a\u003e — copper-binding tripeptide investigated for gene-expression and dermal-ageing research, often co-cited with Epithalon.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/cjc-1295-no-dac-ipamorelin-10mg\"\u003eCJC-1295 + Ipamorelin\u003c\/a\u003e — GH-axis blend cross-referenced in age-related endocrine research.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor more on multi-peptide research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs Epithalon legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eEpithalon is supplied by Optic Labs strictly for laboratory research, development and analytical use. It is not approved by the Therapeutic Goods Administration for human therapeutic use and is not a registered medicine. For a detailed overview of Australian peptide research regulation, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is Epithalon?\u003c\/h3\u003e\n\u003cp\u003eEpithalon is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG), originally derived from the pineal-gland polypeptide complex epithalamin. It is investigated in laboratory research as a regulator of telomerase activity and gene expression. See our \u003ca href=\"\/blogs\/news\/epithalon-australia-telomere-anti-aging-guide\"\u003eEpithalon telomere research guide\u003c\/a\u003e for a deeper overview.\u003c\/p\u003e\n\n\u003ch3\u003eIs Epithalon the same as Epitalon or Epithalong?\u003c\/h3\u003e\n\u003cp\u003eYes — \"Epithalon\", \"Epitalon\" and \"Epithalong\" are spelling variants of the same AEDG tetrapeptide. They refer to the same compound across English, Russian transliteration, and various supplier brand names.\u003c\/p\u003e\n\n\u003ch3\u003eHow is Epithalon supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies Epithalon as a lyophilised powder in glass research vials, available in 10mg. Each vial is sealed and shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with an Epithalon 10mg vial?\u003c\/h3\u003e\n\u003cp\u003eA common laboratory dilution is 2 mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e per 10mg vial, giving a 5 mg\/mL solution. The exact volume depends on your research protocol — see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e for dilution mathematics.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted Epithalon be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted Epithalon should be kept at 2–8°C, protected from light, and used within 30 days. Long-term storage of unreconstituted lyophilised powder should be at −20°C or colder. See our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage complete research guide\u003c\/a\u003e for handling detail.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884777144,"sku":null,"price":52.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/epithalong_7735ba74-f28e-4539-9db9-4777cdbe7243.png?v=1776426194"},{"product_id":"dsip-10mg-15mg","title":"DSIP 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity DSIP in Australia (10mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout DSIP\u003c\/h2\u003e\n\u003cp\u003eDSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide first isolated from the cerebral venous blood of sleeping rabbits in the 1970s. It takes its name from the observation that infusion of the peptide promoted delta-wave (slow-wave) EEG activity in early animal models. DSIP has since become a research tool for laboratory investigation of sleep architecture, hypothalamic–pituitary–adrenal (HPA) axis modulation, and neuroendocrine stress response.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies DSIP as a lyophilised research-grade peptide for laboratories investigating sleep-pattern modulation, circadian biology, stress-axis signalling, and analgesia models. Each vial is third-party HPLC verified at \u0026gt;99% purity. DSIP is supplied for laboratory research use only and is not intended for human consumption, cosmetic application, or any therapeutic purpose.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Delta Sleep-Inducing Peptide (DSIP)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 62568-57-4\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e35\u003c\/sub\u003eH\u003csub\u003e48\u003c\/sub\u003eN\u003csub\u003e10\u003c\/sub\u003eO\u003csub\u003e15\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~848.8 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eDSIP was first isolated by Schoenenberger and Monnier at the University of Basel in the 1970s during cross-circulation studies in rabbits, where blood from sleeping animals appeared to contain a sleep-promoting factor. The active component was sequenced as a nine-residue peptide with no homology to other neuropeptides. Decades of subsequent research have explored DSIP's behaviour across the blood–brain barrier, its interaction with neuroendocrine axes, and its possible endogenous role in sleep regulation.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSlow-wave sleep models\u003c\/strong\u003e — early animal-model research characterised DSIP's promotion of delta-wave EEG activity in rabbit and rodent sleep studies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHPA-axis modulation\u003c\/strong\u003e — published preclinical work has examined DSIP's effect on ACTH, cortisol\/corticosterone and stress-axis signalling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCircadian biology\u003c\/strong\u003e — laboratory studies have profiled DSIP's variation across the sleep–wake cycle and its interaction with melatonin signalling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnalgesia and pain models\u003c\/strong\u003e — animal research has explored DSIP in models of nociception and opioid-receptor cross-talk.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAntioxidant and neuroprotective markers\u003c\/strong\u003e — in vitro work has tracked changes in lipid peroxidation, free-radical markers and cellular stress response in DSIP-exposed neural tissue.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThermoregulation studies\u003c\/strong\u003e — preclinical investigation has examined DSIP's effect on body-temperature regulation in rodent models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTumour-bearing animal models\u003c\/strong\u003e — published research has explored DSIP in stress and disease-resistance contexts in tumour-bearing rodents.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader context on neuropeptide research, see our \u003ca href=\"\/blogs\/news\/semax-australia-nootropic-research-guide\"\u003eSemax nootropic research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eDSIP is supplied as a lyophilised powder and is reconstituted prior to use with sterile \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e. A common laboratory approach is to add 2 mL of bac water to a 10mg vial, yielding a 5 mg\/mL working concentration; at this concentration, 0.1 mL drawn into an insulin syringe corresponds to 500 µg of peptide. Reconstituted DSIP should be stored at 2–8°C, protected from light, and used within 30 days. For step-by-step dilution mathematics, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eIn published neuropeptide and circadian research, DSIP is frequently grouped with other peptides investigated for nervous-system, stress-axis and neuroprotective research:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/semax-10mg\"\u003eSemax\u003c\/a\u003e — heptapeptide investigated for nootropic and BDNF-related research, often referenced alongside DSIP in CNS-research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/selank-10mg\"\u003eSelank\u003c\/a\u003e — tuftsin-PGP heptapeptide studied for anxiolytic and neuroimmune research, complementary to DSIP in stress-axis work.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glutathione-1500mg\"\u003eGlutathione\u003c\/a\u003e — endogenous tripeptide antioxidant cross-referenced with DSIP in oxidative-stress and neuroprotective research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/epithalong-10mg\"\u003eEpithalon\u003c\/a\u003e — pineal-derived tetrapeptide referenced alongside DSIP in pineal-axis and circadian research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/cjc-1295-no-dac-ipamorelin-10mg\"\u003eCJC-1295 + Ipamorelin\u003c\/a\u003e — GH-axis blend referenced in sleep–GH-secretion research alongside DSIP.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor more on multi-peptide research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs DSIP legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eDSIP is supplied by Optic Labs strictly for laboratory research, development and analytical use. It is not approved by the Therapeutic Goods Administration for human therapeutic use and is not a registered medicine. For a detailed overview of Australian peptide research regulation, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is DSIP?\u003c\/h3\u003e\n\u003cp\u003eDSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide first isolated from the venous blood of sleeping rabbits. It is investigated in laboratory research as a probe for sleep architecture, HPA-axis modulation, and neuroendocrine stress response. See our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e for broader context.\u003c\/p\u003e\n\n\u003ch3\u003eWhat does DSIP research focus on?\u003c\/h3\u003e\n\u003cp\u003ePublished research has examined DSIP in animal models of slow-wave sleep, circadian rhythm, stress-axis signalling, analgesia, thermoregulation and oxidative stress. It is studied as a neuroendocrine research probe rather than a sleep treatment.\u003c\/p\u003e\n\n\u003ch3\u003eHow is DSIP supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies DSIP as a lyophilised powder in glass research vials, available in 10mg. Each vial is sealed and shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a DSIP 10mg vial?\u003c\/h3\u003e\n\u003cp\u003eA common laboratory dilution is 2 mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e per 10mg vial, giving a 5 mg\/mL solution. The exact volume depends on your research protocol — see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e for dilution mathematics.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted DSIP be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted DSIP should be kept at 2–8°C, protected from light, and used within 30 days. Long-term storage of unreconstituted lyophilised powder should be at −20°C or colder. See our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage complete research guide\u003c\/a\u003e for handling detail.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884809912,"sku":null,"price":61.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/dsip_185b75dd-19a4-405e-b7f7-9c71ee49f208.png?v=1776427918"},{"product_id":"cjc-1295-no-dac-ipamorelin-10mg","title":"CJC-1295 no DAC + Ipamorelin 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity CJC-1295 + Ipamorelin blend (10mg) in Australia. Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout CJC-1295 + Ipamorelin\u003c\/h2\u003e\n\u003cp\u003eCJC-1295 (no-DAC) and ipamorelin are two complementary growth-hormone-axis research peptides that are frequently co-studied as a blend. CJC-1295 (no-DAC), also known as Mod GRF 1-29, is a tetrasubstituted analogue of growth-hormone-releasing hormone (GHRH 1-29) that binds the GHRH receptor on somatotrophs of the anterior pituitary. Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist — a pentapeptide growth hormone secretagogue. In published endocrinology research, the two peptides act on distinct but complementary pathways: GHRH-receptor activation increases the amplitude of natural GH pulses, while a selective GH secretagogue can synergistically increase pulse frequency.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies CJC-1295 (no-DAC) and ipamorelin as a co-lyophilised research blend at 10mg total fill (5mg CJC-1295 + 5mg ipamorelin), third-party HPLC tested to \u0026gt;99% purity for each component. The product is distributed Australian-domestic from Sydney, NSW, for in vitro and laboratory research applications. The blend is supplied strictly for laboratory research, development or analytical use and is not intended for human consumption.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e CJC-1295 (no-DAC, also known as Mod GRF 1-29) co-lyophilised with ipamorelin\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS numbers:\u003c\/strong\u003e CJC-1295 (no-DAC): 863288-34-0; ipamorelin: 170851-70-4\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e CJC-1295 (no-DAC): C\u003csub\u003e152\u003c\/sub\u003eH\u003csub\u003e252\u003c\/sub\u003eN\u003csub\u003e44\u003c\/sub\u003eO\u003csub\u003e42\u003c\/sub\u003e; ipamorelin: C\u003csub\u003e38\u003c\/sub\u003eH\u003csub\u003e49\u003c\/sub\u003eN\u003csub\u003e9\u003c\/sub\u003eO\u003csub\u003e5\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e CJC-1295 (no-DAC): ~3367.9 g\/mol; ipamorelin: ~711.85 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence (CJC-1295 no-DAC):\u003c\/strong\u003e Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence (ipamorelin):\u003c\/strong\u003e Aib-His-D-2-Nal-D-Phe-Lys-NH\u003csub\u003e2\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder (combined fill)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC for each component\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable size:\u003c\/strong\u003e 10mg total (5mg CJC-1295 no-DAC + 5mg ipamorelin)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eCJC-1295 (no-DAC) was developed by ConjuChem in the early 2000s as a stabilised GHRH analogue, with four amino-acid substitutions to the native GHRH 1-29 sequence that resist proteolytic degradation. The \"no-DAC\" variant lacks the drug affinity complex linker present on the longer-acting CJC-1295 with DAC, giving it a shorter functional duration that more closely matches natural GH pulse kinetics. Ipamorelin was developed by Novo Nordisk as a selective GHS-R1a agonist designed to stimulate GH release without significant cortisol or prolactin responses, in contrast to earlier ghrelin-receptor agonists such as GHRP-6 and GHRP-2.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDual-pathway GH stimulation:\u003c\/strong\u003e in published endocrinology research, GHRH-receptor agonism (CJC-1295) and ghrelin-receptor agonism (ipamorelin) act through complementary intracellular pathways, with the combination producing larger GH pulses than either alone in animal model and isolated pituitary cell research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePulsatile release pattern:\u003c\/strong\u003e in animal models, the no-DAC variant of CJC-1295 has been studied for its capacity to amplify GH pulses while preserving the natural pulsatile pattern, distinguishing it from continuous-exposure GH-axis research compounds.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSelectivity profile (ipamorelin):\u003c\/strong\u003e in receptor-binding and rodent endocrine studies, ipamorelin showed minimal stimulation of cortisol, prolactin or aldosterone, distinguishing it from non-selective GHS such as GHRP-6.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIGF-1 axis:\u003c\/strong\u003e in animal model research, GH-axis stimulation by CJC-1295 + ipamorelin has been associated with downstream increases in IGF-1, the principal mediator of many of GH's tissue effects.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBody composition models:\u003c\/strong\u003e in rodent research, GH-axis stimulation has been studied in connection with adipose tissue lipolysis and lean mass parameters.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSleep architecture research:\u003c\/strong\u003e in published research, GH-axis activity is closely tied to slow-wave sleep, and GH-secretagogue research peptides have been studied in models of sleep architecture.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRecovery and tissue research:\u003c\/strong\u003e GH\/IGF-1 axis activity is studied in animal model research on connective tissue, bone metabolism and post-injury recovery.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary, see our \u003ca href=\"\/blogs\/news\/cjc-1295-ipamorelin-growth-hormone-stack-guide\"\u003eCJC-1295 + ipamorelin GH stack research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eThe combined 10mg vial reconstitutes readily in \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e. A common laboratory approach is reconstitution in 2ml to yield a 5mg\/ml total working stock (corresponding to 2.5mg\/ml CJC-1295 + 2.5mg\/ml ipamorelin), or in 5ml for a 2mg\/ml total stock (1mg\/ml of each component). The bacteriostatic water should be drawn into a sterile syringe and injected slowly down the inside wall of the lyophilised vial, with the peptide cake allowed to dissolve passively rather than through agitation. Reconstituted blend should be aliquoted, refrigerated at 2–8°C and protected from light, with research stocks typically used within 30 days. For dilution maths across alternative volumes, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e. For long-term storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eIn published research and laboratory protocols, CJC-1295 + ipamorelin is often co-investigated alongside other recovery, body-composition and longevity research peptides:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/bpc-157\"\u003eBPC-157\u003c\/a\u003e — pentadecapeptide co-investigated with GH-axis research peptides in tissue-repair and recovery models.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tb-500\"\u003eTB-500\u003c\/a\u003e — Thymosin β4 fragment commonly examined alongside GH-axis stimulation in injury and recovery research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tesamorelin-10mg\"\u003eTesamorelin\u003c\/a\u003e — alternative GHRH analogue studied in body composition and visceral adipose tissue research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/sermorelin-10mg\"\u003eSermorelin\u003c\/a\u003e — shorter GHRH 1-29 analogue investigated in endocrine research as an alternative GHRH-axis compound.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/nad-1000mg\"\u003eNAD+\u003c\/a\u003e — co-investigated alongside GH-axis research compounds in longevity and mitochondrial study designs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader context on combined research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs CJC-1295 + ipamorelin legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eCJC-1295 and ipamorelin are not registered therapeutic goods in Australia, and growth-hormone-releasing peptides are subject to specific regulatory oversight by the Therapeutic Goods Administration. Optic Labs supplies the CJC-1295 + ipamorelin blend strictly for laboratory, research and analytical use only, not as a therapeutic good. For a full overview of how the TGA treats research peptides in Australia, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003epeptide legality and TGA compliance guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is CJC-1295 + ipamorelin?\u003c\/h3\u003e\n\u003cp\u003eCJC-1295 (no-DAC) is a stabilised GHRH 1-29 analogue that activates the GHRH receptor; ipamorelin is a selective ghrelin-receptor (GHS-R1a) agonist. The two are co-supplied as a research blend because they activate complementary pathways of GH release in published endocrinology research. For a research-level summary, see our \u003ca href=\"\/blogs\/news\/cjc-1295-ipamorelin-growth-hormone-stack-guide\"\u003eCJC-1295 + ipamorelin research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is the difference between CJC-1295 with DAC and CJC-1295 without DAC?\u003c\/h3\u003e\n\u003cp\u003eThe \"DAC\" (drug affinity complex) is a maleimide linker that binds CJC-1295 to serum albumin, extending its functional half-life from hours to several days. CJC-1295 with DAC produces sustained GHRH-receptor exposure, while CJC-1295 no-DAC (Mod GRF 1-29) produces shorter pulses that more closely resemble the natural pulsatile pattern of GH release. Optic Labs supplies the no-DAC variant in this blend, which is the variant most commonly co-investigated with ipamorelin in published research.\u003c\/p\u003e\n\n\u003ch3\u003eWhy are CJC-1295 and ipamorelin commonly studied together?\u003c\/h3\u003e\n\u003cp\u003eThe two peptides act through distinct receptors — the GHRH receptor and the ghrelin receptor — that converge on the same somatotroph cell population in the anterior pituitary. In published endocrinology research, simultaneous activation of both pathways produces larger GH pulses than either compound alone, providing a useful tool for studying maximal physiological GH release.\u003c\/p\u003e\n\n\u003ch3\u003eHow is the blend supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies CJC-1295 (no-DAC) and ipamorelin as a co-lyophilised powder in 10mg glass research vials (5mg of each component). Each vial is sealed with a tamper-evident closure. Certificates of analysis showing HPLC purity testing for each component are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a 10mg blend vial?\u003c\/h3\u003e\n\u003cp\u003eFor the 10mg combined vial, 2ml of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a 5mg\/ml total working stock (2.5mg of each peptide per ml); 5ml yields a 2mg\/ml total stock (1mg of each per ml); 1ml yields a 10mg\/ml stock (5mg of each per ml). Choose a volume based on the concentrations required by the research protocol. For a worked example, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eHow should the reconstituted blend be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted CJC-1295 + ipamorelin should be stored at 2–8°C, protected from light, and used within approximately 30 days. For longer-term storage, aliquoting and freezing at −20°C or below is preferred to limit freeze-thaw degradation. Full handling protocols are covered in our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360884940984,"sku":null,"price":94.99,"currency_code":"AUD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/cjcnodacipa10_b8fecb4a-8ce2-4e95-a59d-de0a9c3ec796.png?v=1776427781"},{"product_id":"bpc-157-tb-500-10mg-20mg","title":"BPC-157 + TB-500 10mg \/ 20mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity BPC-157 + TB-500 blend in Australia (10mg \/ 20mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout the BPC-157 + TB-500 blend\u003c\/h2\u003e\n\u003cp\u003eThe BPC-157 + TB-500 blend pairs two of the most extensively studied research peptides in tissue-repair and regenerative biology in a single lyophilised vial. BPC-157, a stable 15-amino-acid pentadecapeptide derived from a fragment of human gastric juice protein BPC, has been characterised in published research for its effects on angiogenesis, growth-factor signalling and connective-tissue repair across a wide range of injury models. TB-500 is a synthetic 17-amino-acid fragment of thymosin β-4 (Tβ4) corresponding to the actin-binding region, studied for its effects on cell migration, actin remodelling and microvascular development. Combined in equal-mass ratios, the blend is a frequently chosen tool in animal-model research where complementary repair pathways are examined in parallel.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies the BPC-157 + TB-500 blend in Australia as a co-lyophilised powder in two formats — 10mg total (5mg BPC-157 + 5mg TB-500) and 20mg total (10mg BPC-157 + 10mg TB-500) — third-party HPLC verified at \u0026gt;99% purity for both peptides. The blend is supplied strictly for laboratory research use only and is not intended for human consumption, clinical, cosmetic, diagnostic or veterinary application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e BPC-157 + TB-500 co-lyophilised blend\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157 CAS:\u003c\/strong\u003e 137525-51-0  |  \u003cstrong\u003eTB-500 CAS:\u003c\/strong\u003e 77591-33-4\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBPC-157 sequence:\u003c\/strong\u003e Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (pentadecapeptide, ~1419.5 g\/mol)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTB-500 sequence:\u003c\/strong\u003e Ac-LKKTETQ (active fragment of thymosin β-4 17-mer, ~889.0 g\/mol; full TB-500 17-mer ~1894.2 g\/mol depending on supplier definition)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder (co-formulated)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC for each peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 10mg total (5mg + 5mg) and 20mg total (10mg + 10mg)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eBPC-157 and TB-500 are often co-studied because their published mechanisms operate on complementary axes of tissue repair — BPC-157 on angiogenic, nitric-oxide and growth-factor pathways; TB-500 on actin sequestration, cell migration and microvasculature. Researchers combine them to probe whether parallel pathway engagement produces additive or distinct effects in connective-tissue, gastrointestinal and cardiovascular injury models.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eBPC-157: tendon-to-bone and ligament-healing models examining fibroblast proliferation and outgrowth in rats and rabbits.\u003c\/li\u003e\n\u003cli\u003eBPC-157: gastrointestinal-protection research in models of ulcerative damage, inflammatory bowel disease and short-bowel syndrome.\u003c\/li\u003e\n\u003cli\u003eBPC-157: angiogenic and VEGF\/eNOS pathway signalling in wound and vascular research.\u003c\/li\u003e\n\u003cli\u003eTB-500: G-actin sequestration and actin-cytoskeleton remodelling in cell-migration assays.\u003c\/li\u003e\n\u003cli\u003eTB-500: cardiac-repair models examining epicardial cell activation and capillary density post-infarction.\u003c\/li\u003e\n\u003cli\u003eTB-500: corneal, dermal and hair-follicle research examining keratinocyte and endothelial migration.\u003c\/li\u003e\n\u003cli\u003eCombined in-vivo studies in rodent musculoskeletal-injury models examining whether co-administration alters repair time-course versus single-peptide arms.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor deeper background on each peptide, see our \u003ca href=\"\/blogs\/news\/bpc-157-tb-500-stack-research-guide\"\u003eBPC-157 + TB-500 stack research guide\u003c\/a\u003e, our \u003ca href=\"\/blogs\/news\/bpc-157-complete-research-guide-2025\"\u003eBPC-157 complete research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/tb-500-australia-thymosin-injury-research-guide\"\u003eTB-500 thymosin β-4 research guide\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eThe blend is supplied co-lyophilised, meaning both peptides are dissolved together when the vial is reconstituted. Use sterile \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e. For the 10mg blend (5mg + 5mg), adding 2mL of bacteriostatic water yields 2.5mg\/mL of each peptide (5mg\/mL total peptide); 1mL gives 5mg\/mL of each (10mg\/mL total). For the 20mg blend (10mg + 10mg), 2mL of bacteriostatic water gives 5mg\/mL of each peptide (10mg\/mL total). Add diluent slowly down the side of the vial — do not inject directly onto the lyophilised cake — and allow the powder to dissolve without vigorous shaking. Reconstituted blend should be stored at 2–8°C, protected from light, and used within 30 days. For worked dilution examples for any vial size, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution calculator guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eThe BPC-157 + TB-500 blend sits at the centre of the broader tissue-repair and regenerative-research family. Researchers studying related repair pathways often hold the constituent peptides on hand individually, alongside connective-tissue and anti-inflammatory tools:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/bpc-157\"\u003eBPC-157\u003c\/a\u003e — single-compound vial for protocols that require BPC-157 alone or at a non-1:1 ratio to TB-500.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tb-500\"\u003eTB-500\u003c\/a\u003e — single-compound vial for protocols that require TB-500 alone.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ghk-cu-50mg-100mg\"\u003eGHK-Cu\u003c\/a\u003e — copper-binding tripeptide studied in collagen synthesis, dermal repair and angiogenesis research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/kpv-10mg\"\u003eKPV\u003c\/a\u003e — α-MSH-derived tripeptide examined in anti-inflammatory and gut-barrier research, often run alongside repair stacks.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glow70-bpc-157-10mg-ghk-cu-50mg-tb-500-10mg\"\u003eGLOW70 stack\u003c\/a\u003e — pre-blended BPC-157 + GHK-Cu + TB-500 for researchers needing a three-compound combination.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader stack-design context, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs the BPC-157 + TB-500 blend legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eNeither BPC-157 nor TB-500 is an approved therapeutic good in Australia, and neither peptide is registered with the Therapeutic Goods Administration (TGA). Optic Labs supplies the blend strictly for laboratory research, development and analytical use — not for human consumption, clinical or cosmetic application. For a detailed overview of how research peptides sit within the Australian regulatory framework, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is the BPC-157 + TB-500 blend?\u003c\/h3\u003e\n\u003cp\u003eIt is a co-lyophilised vial containing equal masses of BPC-157 (a pentadecapeptide derived from gastric juice protein BPC) and TB-500 (a fragment of thymosin β-4). The two peptides are widely studied together in tissue-repair, gastrointestinal and cardiovascular injury models. For background on each, see our \u003ca href=\"\/blogs\/news\/bpc-157-tb-500-stack-research-guide\"\u003eBPC-157 + TB-500 stack research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhy use a blend instead of running BPC-157 and TB-500 from separate vials?\u003c\/h3\u003e\n\u003cp\u003eA co-lyophilised blend reduces handling steps and the number of reconstitution events, which is convenient when a research protocol consistently uses the two peptides at a 1:1 mass ratio. For protocols that require unequal ratios, dose-escalation across one peptide while holding the other constant, or single-peptide arms, separate \u003ca href=\"\/products\/bpc-157\"\u003eBPC-157\u003c\/a\u003e and \u003ca href=\"\/products\/tb-500\"\u003eTB-500\u003c\/a\u003e vials are the appropriate choice.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a BPC-157 + TB-500 vial?\u003c\/h3\u003e\n\u003cp\u003eFor the 10mg blend (5mg BPC-157 + 5mg TB-500), 2mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e gives 2.5mg\/mL of each peptide. For the 20mg blend (10mg + 10mg), 2mL gives 5mg\/mL of each. See our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e for additional worked examples.\u003c\/p\u003e\n\n\u003ch3\u003eHow should the reconstituted blend be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted blend should be stored at 2–8°C, protected from light, and used within 30 days. Lyophilised vials are stable at 2–8°C until reconstitution. For full handling guidance, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"10mg","offer_id":53360884973752,"sku":null,"price":94.99,"currency_code":"AUD","in_stock":false},{"title":"20mg","offer_id":53360885006520,"sku":null,"price":132.99,"currency_code":"AUD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/wolf10.png?v=1776426196"},{"product_id":"bac-water-3ml-10ml","title":"BAC Water 3ml \/ 10ml","description":"\u003cp\u003e\u003cstrong\u003eBuy bacteriostatic water in Australia (3ml and 10ml). Sterile, 0.9% benzyl alcohol preserved water for laboratory peptide reconstitution. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout bacteriostatic water\u003c\/h2\u003e\n\u003cp\u003eBacteriostatic water (BAC water) is sterile water for injection containing 0.9% benzyl alcohol as a bacteriostatic preservative. The benzyl alcohol inhibits the growth of most common bacteria, which allows the same vial to be punctured multiple times across a research protocol without rapid microbial colonisation — a key practical advantage over plain sterile water for injection (SWFI). In peptide and protein research, bacteriostatic water is the standard reconstitution diluent for lyophilised compounds where the working stock will be used over several days or weeks.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies bacteriostatic water in 3ml and 10ml multi-dose research vials, distributed Australian-domestic from Sydney, NSW. The product is manufactured to research-grade specifications and supplied strictly for laboratory research, development or analytical use, not for human or veterinary administration.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Bacteriostatic water for research use\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition:\u003c\/strong\u003e Water for injection USP equivalent + 0.9% w\/v benzyl alcohol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreservative:\u003c\/strong\u003e Benzyl alcohol (CAS 100-51-6)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003epH range:\u003c\/strong\u003e Approximately 4.5–7.0\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Sterile clear liquid in sealed multi-dose research vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSterility:\u003c\/strong\u003e Filter-sterilised to research-grade specifications\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 3ml vial, 10ml vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage (sealed):\u003c\/strong\u003e Room temperature (15–25°C), protected from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage (after first puncture):\u003c\/strong\u003e 2–8°C, used within 28 days\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eBacteriostatic water has been a standard pharmacopoeial diluent since the 1940s, when benzyl alcohol was introduced as a multi-use preservative for parenteral preparations. In modern peptide research, BAC water is preferred over plain sterile water because of two practical realities: lyophilised peptide vials are typically over-filled (giving 30–60 days of working stock), and laboratories need a diluent that tolerates repeated stopper puncture without microbial bloom.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBenzyl alcohol mechanism:\u003c\/strong\u003e in microbiology research, benzyl alcohol disrupts bacterial membrane integrity at low concentrations, providing bacteriostatic (growth-inhibiting) — not bactericidal — activity against common skin and air contaminants.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePeptide stability in BAC water:\u003c\/strong\u003e in cell-culture studies, most lyophilised peptides reconstituted in 0.9% benzyl alcohol water remain biochemically stable at 2–8°C for 28–30 days, validating the standard \"use within 30 days\" handling rule.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompatibility with sensitive compounds:\u003c\/strong\u003e in published research, benzyl alcohol is generally considered compatible with peptides such as BPC-157, TB-500, GHK-Cu, growth-hormone-releasing peptides and most short-chain analogues; researchers working with paediatric or neonatal cell models often select preservative-free SWFI instead because of historical concerns at very high benzyl alcohol exposures.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMulti-dose puncture studies:\u003c\/strong\u003e standard handling protocols are based on 28-day post-puncture sterility data underpinning USP and BP monographs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComparison to other diluents:\u003c\/strong\u003e sterile water for injection (SWFI), 0.9% saline and acetic-acid buffers are alternative diluents used in specialised research applications; selection depends on peptide solubility and downstream assay requirements.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReconstitution dilution maths:\u003c\/strong\u003e the volume of BAC water added to a lyophilised vial determines the mg\/ml concentration of the working stock; standard dilutions are documented per peptide in the relevant research literature.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage research:\u003c\/strong\u003e reconstituted peptide stability is most strongly affected by temperature, light exposure and freeze-thaw cycling rather than by the preservative itself.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary, see our \u003ca href=\"\/blogs\/news\/bacteriostatic-water-peptide-research-complete-guide\"\u003ebacteriostatic water research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution calculator guide\u003c\/a\u003e. For long-term handling protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eBacteriostatic water itself does not require reconstitution — it is supplied ready to use as a diluent. The standard laboratory workflow is to wipe the rubber stopper of both the BAC water vial and the lyophilised peptide vial with an alcohol swab, withdraw the chosen volume of BAC water with a sterile syringe, and inject it slowly down the inside wall of the lyophilised vial without disturbing the peptide cake. The peptide is then allowed to dissolve passively rather than being shaken. For specific dilution examples — including 5ml into a 5mg vial yielding a 1mg\/ml stock — see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e. After first puncture, BAC water vials should be refrigerated at 2–8°C and used within 28 days. Each Optic Labs BAC water vial is suitable for reconstituting multiple peptide vials over its in-use lifetime.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly paired research peptides\u003c\/h2\u003e\n\u003cp\u003eBacteriostatic water is the standard reconstitution diluent for virtually every lyophilised research peptide supplied by Optic Labs. The following are among the most commonly reconstituted with BAC water:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/bpc-157\"\u003eBPC-157\u003c\/a\u003e — pentadecapeptide reconstituted in BAC water for tissue-repair and gastrointestinal research models.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tb-500\"\u003eTB-500\u003c\/a\u003e — Thymosin β4 fragment commonly paired with BPC-157 in injury and repair research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ghk-cu-50mg-100mg\"\u003eGHK-Cu\u003c\/a\u003e — copper tripeptide reconstituted in BAC water for skin, fibroblast and antioxidant cell research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/cjc-1295-no-dac-ipamorelin-10mg\"\u003eCJC-1295 + Ipamorelin\u003c\/a\u003e — GH-axis research blend reconstituted in BAC water for endocrine and metabolic models.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/reta-10mg-15mg-20mg-30mg\"\u003eRetatrutide\u003c\/a\u003e — GLP-1\/GIP\/glucagon triple-agonist reconstituted in BAC water for metabolic research.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader context on combined research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs bacteriostatic water legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eBacteriostatic water supplied for laboratory research is not classified as a therapeutic good in the same way as injectable medical products are. Optic Labs supplies BAC water strictly as a research diluent, not as a therapeutic good or medical device. For a full overview of how the Therapeutic Goods Administration treats laboratory peptide and reconstitution supplies in Australia, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003epeptide legality and TGA compliance guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is bacteriostatic water?\u003c\/h3\u003e\n\u003cp\u003eBacteriostatic water is sterile water containing 0.9% benzyl alcohol as a preservative that inhibits microbial growth. It is the standard diluent used to reconstitute lyophilised research peptides because it tolerates multiple stopper punctures across a 28-day in-use period. For a full plain-language explainer, see our \u003ca href=\"\/blogs\/news\/bacteriostatic-water-peptide-research-complete-guide\"\u003ebacteriostatic water research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is the difference between bacteriostatic water and sterile water for injection?\u003c\/h3\u003e\n\u003cp\u003eSterile water for injection (SWFI) is single-dose water with no preservative — once the stopper is punctured, the contents must be used immediately and any remainder discarded. Bacteriostatic water contains 0.9% benzyl alcohol, so it can be punctured repeatedly over approximately 28 days while remaining bacteriostatic. For multi-dose peptide research stocks, BAC water is the standard choice; for single-use applications or where benzyl alcohol must be avoided, SWFI is used instead.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I use to reconstitute a peptide vial?\u003c\/h3\u003e\n\u003cp\u003eThe volume depends on the peptide mass and the desired working concentration. As a general worked example, 2ml of BAC water added to a 5mg peptide vial yields a 2.5mg\/ml stock; 5ml added to a 5mg vial yields 1mg\/ml; 2ml added to a 10mg vial yields 5mg\/ml. Each Optic Labs peptide product page lists specific dilution suggestions, and our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e walks through the unit conversions step by step.\u003c\/p\u003e\n\n\u003ch3\u003eHow is bacteriostatic water supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies BAC water as a sterile clear liquid in sealed multi-dose research vials at 3ml and 10ml fill volumes. Each vial has a butyl rubber stopper and a tamper-evident aluminium seal. Certificates of analysis are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow should bacteriostatic water be stored?\u003c\/h3\u003e\n\u003cp\u003eSealed vials can be stored at room temperature (15–25°C), protected from light. After first puncture, vials should be refrigerated at 2–8°C and used within approximately 28 days. Vials should not be frozen, as freezing can compromise stopper integrity. Full handling protocols are covered in our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"3ml","offer_id":53360885039288,"sku":null,"price":6.99,"currency_code":"AUD","in_stock":true},{"title":"10ml","offer_id":53360885072056,"sku":null,"price":12.99,"currency_code":"AUD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/bac3.png?v=1776426194"},{"product_id":"aod-9604-5mg","title":"AOD-9604 5mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity AOD-9604 in Australia (5mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout AOD-9604\u003c\/h2\u003e\n\u003cp\u003eAOD-9604 is a synthetic 16-amino-acid peptide corresponding to the C-terminal fragment (residues 177–191) of human growth hormone, modified with an additional N-terminal tyrosine residue to improve stability. Originally developed at Monash University as part of research into the lipolytic domain of hGH, AOD-9604 retains many of the fat-mobilising characteristics of full-length growth hormone while lacking the broader growth-promoting and insulin-resistance effects associated with the parent molecule. It is widely used as a research probe for adipose-tissue lipolysis and metabolic regulation.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies AOD-9604 as a lyophilised research-grade peptide for laboratories investigating adipocyte lipolysis, β3-adrenergic signalling, and energy-balance pathways. Each vial is third-party HPLC verified at \u0026gt;99% purity. AOD-9604 peptide is supplied for laboratory research use only and is not intended for human consumption, cosmetic application, or any therapeutic purpose.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e AOD-9604 (hGH 177–191 fragment, Tyr-modified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 221231-10-3\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e78\u003c\/sub\u003eH\u003csub\u003e123\u003c\/sub\u003eN\u003csub\u003e23\u003c\/sub\u003eO\u003csub\u003e23\u003c\/sub\u003eS\u003csub\u003e2\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~1815.1 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (with disulfide bridge)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 5mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eAOD-9604 originated from research at Monash University in the 1990s seeking to isolate the lipolytic domain of human growth hormone from its growth-promoting and metabolic-side-effect domains. The 177–191 fragment was identified as the lipolytic active site, and a tyrosine residue was added at the N-terminus to enhance stability. Since then, AOD-9604 has appeared across many lines of preclinical and early-phase clinical research focused on obesity, adipose biology, and articular cartilage models.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdipocyte lipolysis\u003c\/strong\u003e — published in vitro studies have characterised AOD-9604's stimulation of lipolysis in isolated rat and human adipocytes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiet-induced obesity models\u003c\/strong\u003e — animal-model research has explored AOD-9604's effect on body composition, fat-mass markers, and energy expenditure in rodent obesity models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eβ3-adrenergic and lipolytic-pathway research\u003c\/strong\u003e — laboratory work has examined the receptor-independent and β3-adrenergic-related signalling associated with AOD-9604.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInsulin and glucose handling\u003c\/strong\u003e — preclinical investigation has tracked changes in fasting glucose, insulin sensitivity, and hepatic glucose output, distinguishing AOD-9604 from intact hGH.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCartilage and osteoarthritis models\u003c\/strong\u003e — published research has explored AOD-9604 in articular cartilage and chondrocyte models, sometimes in combination with HA or other matrix peptides.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdipose-tissue gene expression\u003c\/strong\u003e — laboratory studies have profiled changes in genes associated with lipolysis, β-oxidation and adipogenesis following AOD-9604 exposure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComparative GH-fragment research\u003c\/strong\u003e — AOD-9604 is frequently used as a comparator alongside other GH-related peptides to characterise the lipolytic-only profile.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary, see our \u003ca href=\"\/blogs\/news\/aod-9604-australia-fat-loss-research-guide\"\u003eAOD-9604 fat loss research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/aod-9604-vs-retatrutide\"\u003eAOD-9604 vs Retatrutide comparison\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eAOD-9604 is supplied as a lyophilised powder and is reconstituted prior to use with sterile \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e. A common laboratory approach is to add 1 mL of bac water to a 5mg vial, yielding a 5 mg\/mL working concentration; at this concentration, 0.1 mL drawn into an insulin syringe corresponds to 500 µg of peptide. Reconstituted AOD-9604 should be stored at 2–8°C, protected from light, and used within 30 days. For step-by-step dilution mathematics, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eIn published metabolic and body-composition research, AOD-9604 is frequently grouped with other peptides investigated for energy-expenditure, GH-axis and adipose research:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/reta-10mg-15mg-20mg-30mg\"\u003eRetatrutide\u003c\/a\u003e — GLP-1\/GIP\/glucagon triple agonist often compared to AOD-9604 in body-composition research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/cjc-1295-no-dac-ipamorelin-10mg\"\u003eCJC-1295 + Ipamorelin\u003c\/a\u003e — GH-axis stack referenced alongside AOD-9604 in growth-hormone-pathway research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tesamorelin-10mg\"\u003eTesamorelin\u003c\/a\u003e — GHRH 1–44 analogue investigated for visceral-adipose research alongside AOD-9604.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/mots-c-10mg-40mg\"\u003eMOTS-c\u003c\/a\u003e — mitochondrial-derived peptide cross-referenced in metabolic-rate research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/5-amino-1mq-10mg\"\u003e5-Amino-1MQ\u003c\/a\u003e — NNMT inhibitor investigated in adipose energy-expenditure research alongside AOD-9604.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor more on multi-peptide research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs AOD-9604 legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eAOD-9604 is supplied by Optic Labs strictly for laboratory research, development and analytical use. It is not approved by the Therapeutic Goods Administration for human therapeutic use and is not a registered medicine. For a detailed overview of Australian peptide research regulation, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is AOD-9604?\u003c\/h3\u003e\n\u003cp\u003eAOD-9604 is a synthetic 16-amino-acid peptide corresponding to the C-terminal lipolytic fragment of human growth hormone (residues 177–191), with an N-terminal tyrosine added for stability. It is studied in laboratory research as a probe for adipose-tissue lipolysis, distinct from full-length hGH. See our \u003ca href=\"\/blogs\/news\/aod-9604-australia-fat-loss-research-guide\"\u003eAOD-9604 research guide\u003c\/a\u003e for a deeper overview.\u003c\/p\u003e\n\n\u003ch3\u003eHow does AOD-9604 differ from full-length hGH in research models?\u003c\/h3\u003e\n\u003cp\u003ePublished research characterises AOD-9604 as retaining the lipolytic domain of hGH while lacking measurable activity at the GH receptor — animal-model studies have therefore reported lipolytic effects without the IGF-1, insulin-resistance or growth-promoting changes associated with intact growth hormone.\u003c\/p\u003e\n\n\u003ch3\u003eHow is AOD-9604 supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies AOD-9604 as a lyophilised powder in glass research vials, available in 5mg. Each vial is sealed and shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with an AOD-9604 5mg vial?\u003c\/h3\u003e\n\u003cp\u003eA common laboratory dilution is 1 mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e per 5mg vial, giving a 5 mg\/mL solution. The exact volume depends on your research protocol — see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e for dilution mathematics.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted AOD-9604 be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted AOD-9604 should be kept at 2–8°C, protected from light, and used within 30 days. Long-term storage of unreconstituted lyophilised powder should be at −20°C or colder. See our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage complete research guide\u003c\/a\u003e for handling detail.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360885104824,"sku":null,"price":75.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/aod_fed6af3d-c7a4-4b4d-9f05-facd0604bcc5.png?v=1776427422"},{"product_id":"5-amino-1mq-10mg","title":"5-Amino-1MQ 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity 5-Amino-1MQ in Australia (10mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout 5-Amino-1MQ\u003c\/h2\u003e\n\u003cp\u003e5-Amino-1MQ (5-amino-1-methylquinolinium iodide) is a small-molecule research compound and a selective inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT consumes S-adenosylmethionine (SAM) and methylates nicotinamide, depleting cellular methyl pools and downstream NAD+ precursors; pharmacological inhibition of NNMT has therefore become a major focus in laboratory research on adipose-tissue energy balance, methyl-donor recycling, and metabolic resilience.\u003c\/p\u003e\n\u003cp\u003eOptic Labs supplies 5-Amino-1MQ as a lyophilised research-grade powder for laboratories investigating NNMT-mediated metabolic pathways, adipocyte biology, and ageing-related cellular remodelling. Each vial is third-party HPLC verified at \u0026gt;99% purity. 5-Amino-1MQ is supplied for laboratory research use only and is not intended for human consumption, cosmetic application, or any therapeutic purpose.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e 5-Amino-1-methylquinolinium iodide (5-Amino-1MQ)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 75413-77-3\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e10\u003c\/sub\u003eH\u003csub\u003e11\u003c\/sub\u003eIN\u003csub\u003e2\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~286.1 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClass:\u003c\/strong\u003e Small-molecule NNMT inhibitor (not a peptide)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e 2–8°C, protect from light. Reconstituted: 2–8°C, used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003e5-Amino-1MQ emerged from medicinal-chemistry programmes screening for selective NNMT inhibitors. NNMT had previously been identified as upregulated in obese adipose tissue, several solid tumours, and ageing tissue more broadly, where its activity correlates with depleted SAM and elevated 1-methylnicotinamide (MNA). 5-Amino-1MQ binds the NNMT active site with high selectivity and is widely used in published research as a chemical probe for NNMT function.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNNMT enzyme inhibition\u003c\/strong\u003e — biochemical studies have characterised 5-Amino-1MQ as a potent, selective NNMT inhibitor in cell-free and cell-culture assays.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdipocyte energy expenditure\u003c\/strong\u003e — published animal models have explored NNMT inhibition with 5-Amino-1MQ in diet-induced-obesity rodents, examining adipose-tissue mass, energy expenditure, and metabolic markers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSAM and methyl-donor pools\u003c\/strong\u003e — laboratory work has tracked changes in cellular SAM, SAH and 1-methylnicotinamide levels following NNMT inhibition.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAD+ salvage interactions\u003c\/strong\u003e — research has examined the relationship between NNMT activity, nicotinamide availability and downstream NAD+ salvage flux.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSkeletal muscle ageing models\u003c\/strong\u003e — preclinical investigation has explored NNMT inhibition in models of age-related muscle dysfunction and stem-cell quiescence.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCancer-cell metabolism studies\u003c\/strong\u003e — NNMT is overexpressed in several cancer cell lines, and 5-Amino-1MQ has been used in vitro to characterise its role in tumour metabolism.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHepatic lipid handling\u003c\/strong\u003e — animal-model studies have examined hepatic steatosis and lipid metabolism following NNMT inhibition.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader context on metabolic and longevity peptide research, see our \u003ca href=\"\/blogs\/news\/nad-plus-australia-longevity-research-guide\"\u003eNAD+ longevity research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003e5-Amino-1MQ is supplied as a lyophilised powder and is reconstituted prior to use with sterile \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e. A common laboratory approach is to add 2 mL of bac water to a 10mg vial, yielding a 5 mg\/mL working concentration; at this concentration, 0.1 mL drawn into an insulin syringe corresponds to 500 µg of compound. As 5-Amino-1MQ is a small molecule rather than a long-chain peptide, it is generally well behaved in solution. Reconstituted material should be stored at 2–8°C, protected from light, and used within 30 days. For step-by-step dilution mathematics, see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eIn published metabolic and longevity research, 5-Amino-1MQ is often referenced alongside other compounds investigated for energy-expenditure, NAD+ and methyl-pool research:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/nad-1000mg\"\u003eNAD+\u003c\/a\u003e — directly relevant to the methyl\/nicotinamide axis modulated by NNMT inhibition.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/reta-10mg-15mg-20mg-30mg\"\u003eRetatrutide\u003c\/a\u003e — GLP-1\/GIP\/glucagon triple agonist studied in adiposity and metabolic-rate research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/aod-9604-5mg\"\u003eAOD-9604\u003c\/a\u003e — hGH (177–191) fragment investigated for adipose lipolysis research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/mots-c-10mg-40mg\"\u003eMOTS-c\u003c\/a\u003e — mitochondrial-derived peptide investigated in metabolic and ageing models.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glutathione-1500mg\"\u003eGlutathione\u003c\/a\u003e — tripeptide antioxidant cross-referenced with 5-Amino-1MQ in redox and methyl-pool research.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor broader context on multi-compound research designs, see our \u003ca href=\"\/blogs\/news\/peptide-research-stacks-australia-combinations\"\u003epeptide research stacks overview\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs 5-Amino-1MQ legal in Australia?\u003c\/h3\u003e\n\u003cp\u003e5-Amino-1MQ is supplied by Optic Labs strictly for laboratory research, development and analytical use. It is not approved by the Therapeutic Goods Administration for human therapeutic use and is not a registered medicine. For a detailed overview of Australian research-compound regulation, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is 5-Amino-1MQ?\u003c\/h3\u003e\n\u003cp\u003e5-Amino-1MQ is a small-molecule research compound that selectively inhibits nicotinamide N-methyltransferase (NNMT). It is not a peptide; it is a methylated quinolinium derivative used as a chemical probe in metabolic and ageing research. See our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003ewhat are peptides explainer\u003c\/a\u003e for broader context on the wider research-compound landscape.\u003c\/p\u003e\n\n\u003ch3\u003eWhat does 5-Amino-1MQ research focus on?\u003c\/h3\u003e\n\u003cp\u003ePublished research has examined 5-Amino-1MQ in cell-culture and animal models of obesity, adipose-tissue energy expenditure, NAD+\/SAM methyl-pool dynamics, hepatic lipid metabolism and ageing-related cellular function. It is studied as an NNMT inhibitor rather than a metabolic or weight-loss treatment.\u003c\/p\u003e\n\n\u003ch3\u003eHow is 5-Amino-1MQ supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies 5-Amino-1MQ as a lyophilised powder in glass research vials, available in 10mg. Each vial is sealed and shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a 5-Amino-1MQ 10mg vial?\u003c\/h3\u003e\n\u003cp\u003eA common laboratory dilution is 2 mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e per 10mg vial, giving a 5 mg\/mL solution. The exact volume depends on your research protocol — see our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e for dilution mathematics.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted 5-Amino-1MQ be stored?\u003c\/h3\u003e\n\u003cp\u003eReconstituted 5-Amino-1MQ should be kept at 2–8°C, protected from light, and used within 30 days. Long-term storage of unreconstituted lyophilised powder should be at −20°C or colder. See our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage complete research guide\u003c\/a\u003e for handling detail.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53360885137592,"sku":null,"price":71.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/5-amino-moq_e958a6b6-e671-4502-a582-1ec7d515da55.png?v=1776427234"},{"product_id":"tb-500","title":"TB-500 5mg \/ 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity TB-500 in Australia (5mg \/ 10mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout TB-500\u003c\/h2\u003e\n\u003cp\u003eTB-500 is a synthetic 17-amino-acid peptide corresponding to the active region (residues 17-23) of Thymosin Beta-4 (Tβ4), a naturally occurring protein found in nearly all human and mammalian tissues. Optic Labs supplies TB-500 as a high-purity lyophilised powder in 5mg and 10mg vials, packaged for in vitro and preclinical laboratory research. Each batch is independently HPLC-tested for purity and identity, with certificates of analysis available on request.\u003c\/p\u003e\n\n\u003cp\u003eTB-500 has been extensively studied in the regenerative biology, cell migration and angiogenesis literature. Published research has investigated its effects on actin sequestration, endothelial cell migration, fibroblast activity and tissue-repair processes in animal-model and cell-culture systems. Optic Labs supplies the compound for laboratory research only — not for human consumption, clinical use, or any therapeutic application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e TB-500 (Thymosin Beta-4 fragment 17-23, acetylated)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 77591-33-4 (Tβ4 parent), TB-500 fragment\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e34\u003c\/sub\u003eH\u003csub\u003e56\u003c\/sub\u003eN\u003csub\u003e10\u003c\/sub\u003eO\u003csub\u003e13\u003c\/sub\u003e (peptide fragment)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~889.0 g\/mol (TB-500 fragment)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence (Tβ4 17-23 region):\u003c\/strong\u003e Ac-LKKTETQ-OH\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised (freeze-dried) white powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 5mg vial \/ 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store unreconstituted vials at 2–8°C; protect from light. Reconstituted solution stored at 2–8°C and used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eThymosin Beta-4 was first identified in the 1980s as a major actin-sequestering protein in eukaryotic cells. The TB-500 fragment used in research preserves the central actin-binding motif of the parent peptide. Published preclinical studies have examined TB-500 in the context of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eActin sequestration and cytoskeletal remodelling in cell-culture models\u003c\/li\u003e\n\u003cli\u003eEndothelial cell migration and capillary tube formation\u003c\/li\u003e\n\u003cli\u003eCardiac, skin and corneal wound-healing animal models\u003c\/li\u003e\n\u003cli\u003eFibroblast and myocyte proliferation studies\u003c\/li\u003e\n\u003cli\u003eAnti-inflammatory and matrix-metalloproteinase pathway research\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary with study citations, see our \u003ca href=\"\/blogs\/news\/tb-500-australia-thymosin-injury-research-guide\"\u003eTB-500 thymosin research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/bpc-157-tb-500-stack-research-guide\"\u003eBPC-157 + TB-500 stack research guide\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eTB-500 is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use in any laboratory protocol. A typical reconstitution for a 5mg vial is 2mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e, yielding a working concentration of 2.5mg\/mL; for a 10mg vial, 2mL yields 5mg\/mL. Exact volumes should be calculated for each protocol — our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e walks through the maths. Reconstituted vials should be stored refrigerated at 2–8°C and protected from light.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eTB-500 is frequently studied alongside other regenerative peptides in published animal-model literature. Researchers working on combined regenerative protocols may be interested in:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/bpc-157\"\u003eBPC-157\u003c\/a\u003e — most frequently co-investigated peptide for tissue-repair research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/bpc-157-tb-500-10mg-20mg\"\u003eBPC-157 + TB-500 blend\u003c\/a\u003e — pre-mixed convenience option\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ghk-cu-50mg-100mg\"\u003eGHK-Cu\u003c\/a\u003e — collagen and skin regeneration research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glow70-bpc-157-10mg-ghk-cu-50mg-tb-500-10mg\"\u003eGLOW Stack\u003c\/a\u003e — BPC-157 + GHK-Cu + TB-500 combined\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/klow80-bpc-157-10mg-ghk-cu-50mg-tb-500-10mg-kpv-10mg\"\u003eKLOW Stack\u003c\/a\u003e — adds KPV for inflammatory pathway research\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs TB-500 legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eTB-500 is not currently approved by the Therapeutic Goods Administration (TGA) for any therapeutic use in Australia. Optic Labs supplies TB-500 strictly as a research chemical for in vitro and preclinical laboratory research — not for human consumption, clinical use or any therapeutic application. For a detailed overview of how Australian peptide regulation works, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is TB-500?\u003c\/h3\u003e\n\u003cp\u003eTB-500 is a synthetic 7-amino-acid peptide fragment corresponding to the central actin-binding region (residues 17-23) of Thymosin Beta-4, a naturally occurring intracellular protein. In published research it has been investigated for its effects on cell migration, angiogenesis and tissue-repair signalling in animal and cell-culture models. See our \u003ca href=\"\/blogs\/news\/tb-500-australia-thymosin-injury-research-guide\"\u003eTB-500 research guide\u003c\/a\u003e for background.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is the difference between TB-500 and Thymosin Beta-4?\u003c\/h3\u003e\n\u003cp\u003eThymosin Beta-4 (Tβ4) is the full 43-amino-acid parent protein. TB-500 refers to a shorter synthetic fragment (residues 17-23) that retains the actin-binding motif. The shorter sequence is the form most commonly used in commercially supplied research peptide work. Our \u003ca href=\"\/blogs\/news\/tb-500-australia-thymosin-injury-research-guide\"\u003eresearch guide\u003c\/a\u003e covers the differences in detail.\u003c\/p\u003e\n\n\u003ch3\u003eHow is TB-500 supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies TB-500 as a lyophilised (freeze-dried) white powder in glass research vials, available in 5mg and 10mg sizes. Each vial is sealed and shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a 5mg or 10mg TB-500 vial?\u003c\/h3\u003e\n\u003cp\u003eReconstitution volume depends on the working concentration required by the research protocol. As a common starting point, 2mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e reconstitutes a 5mg vial at 2.5mg\/mL, or a 10mg vial at 5mg\/mL. Our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution guide\u003c\/a\u003e covers the calculations in detail.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted TB-500 be stored?\u003c\/h3\u003e\n\u003cp\u003eUnreconstituted vials should be stored at 2–8°C and protected from light. Once reconstituted, the solution should be refrigerated at 2–8°C and used within approximately 30 days. For full storage protocols across all peptide forms, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"5mg","offer_id":53360885170360,"sku":null,"price":61.99,"currency_code":"AUD","in_stock":true},{"title":"10mg","offer_id":53360885203128,"sku":null,"price":94.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/tb5.png?v=1776426119"},{"product_id":"bpc-157","title":"BPC-157 5mg \/ 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity BPC-157 in Australia (5mg \/ 10mg). Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout BPC-157\u003c\/h2\u003e\n\u003cp\u003eBPC-157 (Body Protection Compound-157) is a stable, 15-amino-acid synthetic peptide derived from a protein originally isolated from human gastric juice. Optic Labs supplies BPC-157 as a high-purity lyophilised powder in 5mg and 10mg vials, packaged for in vitro and preclinical laboratory research. Each batch is independently lab-tested by HPLC for purity and identity, with certificates of analysis available on request.\u003c\/p\u003e\n\n\u003cp\u003eBPC-157 has become one of the most widely studied research peptides in the angiogenesis, cytoprotection and tissue-repair literature. It has been investigated for its effects on tendon-to-bone healing, gastrointestinal mucosal integrity, vascular development, and modulation of nitric oxide and growth-factor pathways in animal models. Optic Labs supplies the compound for laboratory research only — not for human consumption, clinical use, or any therapeutic application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e BPC-157 (Body Protection Compound-157)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 137525-51-0\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e62\u003c\/sub\u003eH\u003csub\u003e98\u003c\/sub\u003eN\u003csub\u003e16\u003c\/sub\u003eO\u003csub\u003e22\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~1419.55 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 amino acids)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised (freeze-dried) white powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 5mg vial \/ 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store unreconstituted vials at 2–8°C; protect from light. Reconstituted solution stored at 2–8°C and used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eThe BPC-157 sequence is a partial fragment of a larger gastric protein, Body Protection Compound, first characterised in published research in the 1990s. The 15-amino-acid synthetic analogue used in research is stable in human gastric juice and does not require a carrier for in vitro work. Published preclinical studies have examined BPC-157 in the context of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAchilles tendon and ligament healing in rat models\u003c\/li\u003e\n\u003cli\u003eGastrointestinal mucosal protection and inflammatory bowel research\u003c\/li\u003e\n\u003cli\u003eEndothelial cell proliferation and angiogenic signalling (VEGFR2, eNOS pathways)\u003c\/li\u003e\n\u003cli\u003eNitric oxide system interactions\u003c\/li\u003e\n\u003cli\u003eSkeletal muscle and bone regeneration models\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor a more detailed research summary with study citations, see our \u003ca href=\"\/blogs\/news\/bpc-157-complete-research-guide-2025\"\u003ecomplete BPC-157 research guide\u003c\/a\u003e and our \u003ca href=\"\/blogs\/news\/bpc-157-benefits-mechanisms-research\"\u003emechanisms of action article\u003c\/a\u003e. Researchers working with reconstitution should also reference our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003epeptide reconstitution guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eBPC-157 is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use in any laboratory protocol. A typical reconstitution for a 5mg vial is 2mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e, yielding a working concentration of 2.5mg\/mL; for a 10mg vial, 2mL yields 5mg\/mL. Exact volumes should be calculated for each protocol — our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e walks through the maths. Reconstituted vials should be stored refrigerated at 2–8°C and protected from light.\u003c\/p\u003e\n\n\u003ch2\u003eCommonly stacked research peptides\u003c\/h2\u003e\n\u003cp\u003eBPC-157 is frequently studied alongside other regenerative peptides in published animal-model literature. Researchers also working with related compounds may be interested in:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tb-500\"\u003eTB-500 (Thymosin Beta-4 fragment)\u003c\/a\u003e — often co-investigated for tissue-repair research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/bpc-157-tb-500-10mg-20mg\"\u003eBPC-157 + TB-500 blend\u003c\/a\u003e — pre-mixed convenience option for combined research protocols\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/ghk-cu-50mg-100mg\"\u003eGHK-Cu\u003c\/a\u003e — collagen and skin regeneration research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/glow70-bpc-157-10mg-ghk-cu-50mg-tb-500-10mg\"\u003eGLOW Stack\u003c\/a\u003e — BPC-157, GHK-Cu and TB-500 combined\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor the published literature on combined research protocols, see our \u003ca href=\"\/blogs\/news\/bpc-157-tb-500-stack-research-guide\"\u003eBPC-157 + TB-500 stack research guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs BPC-157 legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eBPC-157 is not currently approved by the Therapeutic Goods Administration (TGA) for any therapeutic use in Australia. Optic Labs supplies BPC-157 strictly as a research chemical for in vitro and preclinical laboratory research — not for human consumption, clinical use or any therapeutic application. For a detailed overview of how Australian peptide regulation works, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is BPC-157?\u003c\/h3\u003e\n\u003cp\u003eBPC-157 is a synthetic 15-amino-acid peptide based on a partial sequence of Body Protection Compound, a protein originally isolated from human gastric juice. In published research it has been investigated for its effects on tissue repair, angiogenesis, gastrointestinal mucosal protection and anti-inflammatory signalling in animal and cell-culture models. See our \u003ca href=\"\/blogs\/news\/what-are-peptides-australia-explainer\"\u003epeptide explainer\u003c\/a\u003e for more on what research peptides are.\u003c\/p\u003e\n\n\u003ch3\u003eWhat does BPC-157 research look at?\u003c\/h3\u003e\n\u003cp\u003eThe published preclinical literature on BPC-157 has examined its effects on tendon and ligament healing, GI mucosal integrity, vascular development, nitric oxide system interactions and inflammation markers. Our \u003ca href=\"\/blogs\/news\/bpc-157-benefits-mechanisms-research\"\u003eBPC-157 mechanisms guide\u003c\/a\u003e summarises the major published mechanisms research with citations.\u003c\/p\u003e\n\n\u003ch3\u003eHow is BPC-157 supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies BPC-157 as a lyophilised (freeze-dried) white powder in glass research vials, available in 5mg and 10mg sizes. Each vial is sealed and shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a 5mg or 10mg BPC-157 vial?\u003c\/h3\u003e\n\u003cp\u003eReconstitution volume depends on the working concentration required by the research protocol. As a common starting point, 2mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e reconstitutes a 5mg vial at 2.5mg\/mL, or a 10mg vial at 5mg\/mL. Our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution guide\u003c\/a\u003e covers the calculations in detail.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted BPC-157 be stored?\u003c\/h3\u003e\n\u003cp\u003eUnreconstituted vials should be stored at 2–8°C and protected from light. Once reconstituted, the solution should be refrigerated at 2–8°C and used within approximately 30 days. For full storage protocols across all peptide forms, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease. Optic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"5mg","offer_id":53360885235896,"sku":null,"price":56.99,"currency_code":"AUD","in_stock":false},{"title":"10mg","offer_id":53360885268664,"sku":null,"price":75.99,"currency_code":"AUD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/bpc5.png?v=1776426194"},{"product_id":"tirzepatide-10mg","title":"Tirzepatide 10mg","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity Tirzepatide 10mg in Australia. Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout Tirzepatide\u003c\/h2\u003e\n\u003cp\u003eTirzepatide (research code LY-3298176) is a synthetic 39-amino-acid peptide developed by Eli Lilly as a dual agonist of the glucose-dependent insulinotropic polypeptide receptor (GIP-R) and the glucagon-like peptide-1 receptor (GLP-1R). Optic Labs supplies tirzepatide as a high-purity lyophilised powder in 10mg vials, packaged for in vitro and preclinical laboratory research.\u003c\/p\u003e\n\n\u003cp\u003eEach batch is independently HPLC-tested for purity and identity, with certificates of analysis available on request.\u003c\/p\u003e\n\n\u003cp\u003eTirzepatide is one of the most extensively studied compounds in the recent metabolic research literature, with published Phase 3 clinical trial data examining glycaemic control and body composition in human study populations. Optic Labs supplies tirzepatide for laboratory research only — not for human consumption, clinical use, or any therapeutic application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Tirzepatide (LY-3298176)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 2023788-19-2\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular formula:\u003c\/strong\u003e C\u003csub\u003e225\u003c\/sub\u003eH\u003csub\u003e348\u003c\/sub\u003eN\u003csub\u003e48\u003c\/sub\u003eO\u003csub\u003e68\u003c\/sub\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~4813.5 g\/mol\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMechanism (research context):\u003c\/strong\u003e Dual agonist — GIP-R + GLP-1R\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised (freeze-dried) white powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable sizes:\u003c\/strong\u003e 10mg vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store unreconstituted vials at 2–8°C; protect from light. Reconstituted solution stored at 2–8°C and used within 30 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eTirzepatide was developed as a dual incretin agonist, combining GIP and GLP-1 receptor activity in a single molecule. Published preclinical and clinical research has examined tirzepatide in the context of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eGIP and GLP-1 receptor binding, signalling and downstream pathways\u003c\/li\u003e\n\u003cli\u003eGlycaemic control and insulin sensitivity in type 2 diabetes research models\u003c\/li\u003e\n\u003cli\u003eBody composition and adiposity in animal models and clinical study populations\u003c\/li\u003e\n\u003cli\u003eHepatic lipid metabolism and NAFLD\/MASH research models\u003c\/li\u003e\n\u003cli\u003eGastric emptying and appetite-regulation research\u003c\/li\u003e\n\u003cli\u003ePhase 1, 2 and 3 clinical pharmacokinetic, glycaemic and weight-change studies (SURPASS and SURMOUNT programmes)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eTirzepatide is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use in any laboratory protocol. A 10mg vial reconstituted in 2mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a working concentration of 5mg\/mL; 1mL yields 10mg\/mL.\u003c\/p\u003e\n\n\u003cp\u003eExact volumes should be calculated for each protocol — our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e walks through the maths. Reconstituted vials should be stored refrigerated at 2–8°C and protected from light.\u003c\/p\u003e\n\n\u003ch2\u003eComparisons and related research compounds\u003c\/h2\u003e\n\u003cp\u003eTirzepatide sits within the broader class of incretin and metabolic peptides. Researchers may also be interested in:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/reta-10mg-15mg-20mg-30mg\"\u003eRetatrutide\u003c\/a\u003e — triple agonist (GLP-1 + GIP + glucagon), successor research compound\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/aod-9604-5mg\"\u003eAOD-9604\u003c\/a\u003e — fragment growth-hormone analogue, fat-loss research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tesamorelin-10mg\"\u003eTesamorelin\u003c\/a\u003e — GHRH analogue, lipolysis research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/cjc-1295-no-dac-ipamorelin-10mg\"\u003eCJC-1295 + Ipamorelin\u003c\/a\u003e — growth-hormone-releasing research peptide combination\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/5-amino-1mq-10mg\"\u003e5-Amino-1MQ\u003c\/a\u003e — NNMT inhibitor, metabolic research\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs tirzepatide legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eTirzepatide has been registered with the Therapeutic Goods Administration (TGA) as a prescription-only therapeutic product in Australia under separate brand registrations. Optic Labs does not supply tirzepatide as a therapeutic, prescription or compounded product. Optic Labs supplies tirzepatide strictly as a research chemical for in vitro and preclinical laboratory research — not for human consumption, clinical use or any therapeutic application. For a detailed overview, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is tirzepatide?\u003c\/h3\u003e\n\u003cp\u003eTirzepatide (LY-3298176) is a synthetic 39-amino-acid peptide developed as a dual agonist of the GIP and GLP-1 receptors. In published research it has been investigated for its effects on glycaemic control, body composition, hepatic lipid metabolism and gastric emptying.\u003c\/p\u003e\n\n\u003ch3\u003eHow does tirzepatide differ from semaglutide and retatrutide?\u003c\/h3\u003e\n\u003cp\u003eSemaglutide is a single GLP-1 receptor agonist. Tirzepatide is a dual GLP-1 + GIP agonist. \u003ca href=\"\/products\/reta-10mg-15mg-20mg-30mg\"\u003eRetatrutide\u003c\/a\u003e adds a third receptor target — the glucagon receptor — making it a triple agonist. The published research literature has examined each compound across its own clinical programme, and the receptor profiles differ in mechanism rather than being directly interchangeable.\u003c\/p\u003e\n\n\u003ch3\u003eHow is tirzepatide supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies tirzepatide as a lyophilised powder in a glass research vial at the 10mg size. Each vial is sealed and shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a tirzepatide 10mg vial?\u003c\/h3\u003e\n\u003cp\u003eReconstitution volume depends on the working concentration required by the research protocol. As a starting reference: 10mg in 2mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields 5mg\/mL; 10mg in 1mL yields 10mg\/mL. Our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution guide\u003c\/a\u003e covers the calculations.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted tirzepatide be stored?\u003c\/h3\u003e\n\u003cp\u003eUnreconstituted vials should be stored at 2–8°C and protected from light. Once reconstituted, the solution should be refrigerated at 2–8°C and used within approximately 30 days. For full storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease.\u003c\/p\u003e\n\n\u003cp\u003eOptic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53494794256568,"sku":null,"price":159.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/hf_20260522_084941_32ee276b-124f-4167-873c-b7195697b3e4.png?v=1779439938"},{"product_id":"hgh-15iu","title":"HGH 15iu","description":"\u003cp\u003e\u003cstrong\u003eBuy high-purity HGH (somatropin) 15iu in Australia. Third-party lab tested at \u0026gt;99% purity. Australian-domestic shipping, AUD pricing, supplied for laboratory research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAbout HGH (somatropin)\u003c\/h2\u003e\n\u003cp\u003eHuman growth hormone (HGH), also referred to as somatropin, is a 191-amino-acid recombinant protein with the identical primary sequence to endogenous human growth hormone (hGH). It is produced via recombinant DNA technology in microbial expression systems and purified to research grade. Optic Labs supplies HGH as a high-purity lyophilised powder in 15iu vials, packaged for in vitro and preclinical laboratory research.\u003c\/p\u003e\n\n\u003cp\u003eEach batch is independently HPLC-tested for purity and identity, with certificates of analysis available on request.\u003c\/p\u003e\n\n\u003cp\u003eGrowth hormone has been one of the most extensively studied proteins in endocrine research for several decades, with a published literature spanning receptor pharmacology, IGF-1 axis signalling, body composition and metabolic effects in animal models and human study populations. Optic Labs supplies HGH for laboratory research only — not for human consumption, clinical use, or any therapeutic application.\u003c\/p\u003e\n\n\u003ch2\u003eProduct specifications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Recombinant human growth hormone (somatropin, rhGH)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCAS number:\u003c\/strong\u003e 12629-01-5\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequence:\u003c\/strong\u003e 191 amino acids, identical to endogenous hGH\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e ~22,124 Da (~22 kDa)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProduction:\u003c\/strong\u003e Recombinant DNA technology, microbial expression\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilised (freeze-dried) white powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;99% by HPLC\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAvailable size:\u003c\/strong\u003e 15iu vial (approximately 5mg by mass; 1mg ≈ 3iu)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store unreconstituted vials at 2–8°C; protect from light. Reconstituted solution stored at 2–8°C and used within ~14 days.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOrigin:\u003c\/strong\u003e Manufactured to research-grade specifications, third-party HPLC verified\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eShipping:\u003c\/strong\u003e Australia-wide domestic dispatch from Sydney, NSW\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eResearch background\u003c\/h2\u003e\n\u003cp\u003eRecombinant human growth hormone is one of the most well-characterised proteins in modern endocrinology. Published preclinical and clinical research has examined HGH in the context of:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eGrowth hormone receptor (GHR) binding, JAK2\/STAT5 signalling and downstream gene expression\u003c\/li\u003e\n\u003cli\u003eHepatic IGF-1 synthesis and the GH\/IGF-1 axis\u003c\/li\u003e\n\u003cli\u003eBody composition (lean mass, adipose mass) in animal models and clinical study populations\u003c\/li\u003e\n\u003cli\u003eLipid metabolism, lipolysis and glucose homeostasis\u003c\/li\u003e\n\u003cli\u003eBone density and connective-tissue research\u003c\/li\u003e\n\u003cli\u003eSleep architecture and recovery-research models\u003c\/li\u003e\n\u003cli\u003ePharmacokinetic and pharmacodynamic studies across multiple recombinant somatropin preparations\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eReconstitution and handling\u003c\/h2\u003e\n\u003cp\u003eHGH is supplied as a lyophilised powder and must be reconstituted with bacteriostatic water before use in any laboratory protocol. The recombinant protein is sensitive to mechanical shear — add the diluent slowly down the side of the vial rather than directly onto the powder, and swirl gently to dissolve. Do not shake.\u003c\/p\u003e\n\n\u003cp\u003eA 15iu vial reconstituted in 1.5mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields a working concentration of 10iu\/mL; 3mL yields 5iu\/mL. Exact volumes should be calculated for each protocol — our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution calculator guide\u003c\/a\u003e walks through the maths. Reconstituted vials should be stored refrigerated at 2–8°C, protected from light, and used within approximately 14 days; recombinant proteins degrade faster in solution than smaller synthetic peptides.\u003c\/p\u003e\n\n\u003ch2\u003eComparisons and related research compounds\u003c\/h2\u003e\n\u003cp\u003eRecombinant HGH is the upstream protein in the GH\/IGF-1 research axis. Researchers may also be interested in compounds that act upstream of, or alongside, endogenous growth-hormone release:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/cjc-1295-no-dac-ipamorelin-10mg\"\u003eCJC-1295 + Ipamorelin\u003c\/a\u003e — GHRH analogue + GHRP combination, growth-hormone-releasing research peptide pairing\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/tesamorelin-10mg\"\u003eTesamorelin\u003c\/a\u003e — stabilised GHRH analogue, lipolysis research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/aod-9604-5mg\"\u003eAOD-9604\u003c\/a\u003e — fragment hGH analogue (residues 176–191), fat-loss research\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"\/products\/mots-c-10mg-40mg\"\u003eMOTS-C\u003c\/a\u003e — mitochondrial-derived peptide, metabolic research\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eFrequently asked questions\u003c\/h2\u003e\n\n\u003ch3\u003eIs HGH legal in Australia?\u003c\/h3\u003e\n\u003cp\u003eRecombinant human growth hormone (somatropin) is registered with the Therapeutic Goods Administration (TGA) as a Schedule 4 prescription-only therapeutic medicine in Australia under multiple brand registrations. Optic Labs does not supply HGH as a therapeutic, prescription or compounded product, and HGH from Optic Labs is not intended for personal, clinical or therapeutic use. Optic Labs supplies HGH strictly as a research-grade material for in vitro and preclinical laboratory research only. For a detailed overview of peptide legality in Australia, see our \u003ca href=\"\/blogs\/news\/are-peptides-legal-australia-tga-compliance-2025\"\u003eguide to peptide legality and TGA compliance in Australia\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is HGH?\u003c\/h3\u003e\n\u003cp\u003eHGH (human growth hormone, also called somatropin or rhGH when produced recombinantly) is a 191-amino-acid protein hormone with the same primary sequence as endogenous human growth hormone. In published research it has been investigated extensively for its effects on body composition, IGF-1 axis signalling, lipid metabolism, bone metabolism and recovery-related processes.\u003c\/p\u003e\n\n\u003ch3\u003eHow does HGH differ from research peptides like CJC-1295, ipamorelin or tesamorelin?\u003c\/h3\u003e\n\u003cp\u003eHGH is growth hormone itself — a full 191-amino-acid recombinant protein. \u003ca href=\"\/products\/cjc-1295-no-dac-ipamorelin-10mg\"\u003eCJC-1295\u003c\/a\u003e and tesamorelin are GHRH analogues, and ipamorelin is a GHRP — they act upstream of the pituitary to stimulate endogenous growth-hormone release. The research literature treats them as different tools that probe different parts of the same axis: HGH provides exogenous protein directly; GHRH\/GHRP compounds modulate endogenous release.\u003c\/p\u003e\n\n\u003ch3\u003eHow is HGH supplied?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs supplies HGH as a lyophilised powder in a sealed glass research vial at the 15iu size (approximately 5mg by mass). Each vial is shipped with a tamper-evident seal. Certificates of analysis showing HPLC purity testing are available on request.\u003c\/p\u003e\n\n\u003ch3\u003eHow much bacteriostatic water do I mix with a HGH 15iu vial?\u003c\/h3\u003e\n\u003cp\u003eReconstitution volume depends on the working concentration required by the research protocol. As a starting reference: 15iu in 1.5mL of \u003ca href=\"\/products\/bac-water-3ml-10ml\"\u003ebacteriostatic water\u003c\/a\u003e yields 10iu\/mL; 15iu in 3mL yields 5iu\/mL. Add the diluent slowly down the side of the vial and swirl gently to dissolve — do not shake, as recombinant proteins are sensitive to mechanical shear. Our \u003ca href=\"\/blogs\/news\/peptide-reconstitution-calculator-guide-australia\"\u003ereconstitution guide\u003c\/a\u003e covers the calculations.\u003c\/p\u003e\n\n\u003ch3\u003eHow should reconstituted HGH be stored?\u003c\/h3\u003e\n\u003cp\u003eUnreconstituted vials should be stored at 2–8°C and protected from light. Once reconstituted, the solution should be refrigerated at 2–8°C and used within approximately 14 days. Recombinant proteins are more stability-sensitive than smaller synthetic peptides — do not freeze and thaw, and minimise warming-cooling cycles. For full storage protocols, see our \u003ca href=\"\/blogs\/news\/peptide-storage-complete-research-guide\"\u003epeptide storage guide\u003c\/a\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhere does Optic Labs ship to?\u003c\/h3\u003e\n\u003cp\u003eOptic Labs ships Australia-wide from Sydney, NSW. Standard dispatch is next business day on orders received before the daily cut-off. International shipping is not currently offered.\u003c\/p\u003e\n\n\u003ch2\u003eLegal disclaimer\u003c\/h2\u003e\n\u003cp\u003eAll products on this site are supplied for \u003cstrong\u003elaboratory research, development or analytical use only\u003c\/strong\u003e. They are not for human consumption, clinical use, or any diagnostic, cosmetic or veterinary application. These products and statements have not been evaluated by the \u003cstrong\u003eTherapeutic Goods Administration (TGA)\u003c\/strong\u003e or the \u003cstrong\u003eAPVMA\u003c\/strong\u003e and are not intended to diagnose, treat, cure or prevent any disease.\u003c\/p\u003e\n\n\u003cp\u003eOptic Labs is not a \u003cstrong\u003ecompounding pharmacy\u003c\/strong\u003e or manufacturing facility as defined under the \u003cem\u003eTherapeutic Goods Act 1989\u003c\/em\u003e, and is not a registered provider of scheduled medicines or therapeutic goods.\u003c\/p\u003e","brand":"Optic Labs","offers":[{"title":"Default Title","offer_id":53494987129016,"sku":null,"price":99.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0952\/4196\/1656\/files\/hf_20260417_085411_ccca53cc-dda8-4911-8f1e-d14158fbf737.png?v=1779440731"}],"url":"https:\/\/opticlabsau.com\/collections\/peptides-australia.oembed?page=2","provider":"Optic Labs","version":"1.0","type":"link"}